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Abbreviations  
Α-1-ACT alpha -1-antichymotrypsin 
ACE angiotensin-converting enzyme 
AHRQ Agency for Healthcare Research and Quality 
AI average intake 
ANR average nutrient requirement 
ApoE apolipoprotein E 
AR average requirement 
b-car beta-carotene 
BMD bone mineral density 
BPG best practice guidelines 
CASP critical appraisal skills programme;  
CC correlation coefficients 
CD2, CD4, CD19 cluster of differentiation 2, 4 and 19;  
CEE Central and Eastern Europe 
CHD coronary heart disease  
CRP C-reactive protein 
Cu copper 
CV coefficient of variation 
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CVD cardiovascular disease  
DACH German-speaking countries (Germany, Austria, Switzerland etc) 
DFE dietary folate equivalent 
DR dietary records 
DRI dietary reference intake 
DRV dietary reference value 
EAR estimated average requirement 
EBP evidence based policy 
EC European Commission 
EFSA European Food Safety Authority  
ENA Early Nutrition Academy 
ENHR European Nutrition Health Report 
ENO European Nutrigenomics Organisation 
EU European Union 
EU27 The European Union (EU) is an economic and political union or 
confederation of 27 member states located primarily in Europe.  
EURRECA  EURopean micronutrient RECommendations Aligned Network of 
Excellence 
FAO Food and Agriculture Organisation 
FBDG food-based dietary guidelines 
FCDB food composition database 
Fe iron 
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FFQ food frequency questionnaire 
FSA Food Standards Agency UK 
GDS geriatric depression scale 
GPx glutathione peroxidase;  
GST glutathione S transferase 
GSTM1  glutathione S-transferase Mu 1 gene;  
GSTT1  glutathione S-transferase theta 1 gene;  
HBS household budget survey 
HIV  human immunodeficiency virus;  
i.m.   intramuscular 
ICCIDD  International Council for the Control of Iodine Deficiency Disorders  
ID  iron deficiency 
IDA  iron deficiency anaemia 
IDD  iodine deficiency disorders 
IDE  iron deficiency erythropoiesis 
IL  interleukin 
IL-1  interleukin-1;  
ILSI  International Life Sciences Institute 
IOM  North American Institute of Medicine 
I-S-H intake - status – health 
IU  international unit 
LBW  low birth weight 
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LRNI lower reference nutrient intake 
LTI lower threshold intake 
Mg  magnesium 
MMSE  mini-mental state examination 
MTHFR  methylenetetrahydrofolate reductase  
MT1A  metallothionein 1A gene;  
NHANES  National Health and Nutrition Examination Survey  
NO  nitric oxide 
NoE  Network of Excellence 
NORDEN  Nordic Council of Ministers 
NRSB  nutrient recommendation setting body 
NTD  neural tube defect 
NuGO Nutrigenomics Organisation 
NuGOwiki  European Nutrigenomics Organisation webpages link  
PGE2 prostaglandin E2 
PGF2a  prostaglandin F2a 
PRI  population reference intake 
PSS  perceived stress scale 
PTH  parathyroid hormone 
RAF risk assessment framework 
RCF  red cell folate 
RCT  randomised controlled trial 
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RDA  recommended dietary allowance 
RNI  reference nutrient intake 
SAB  scientific advisory body 
SAC  scientific advisory committee (or council) 
SACN  UK Scientific Advisory Committee on Nutrition 
SBP2  selenocysteine insertion sequence  
Se  selenium 
SEBR  systematic evidence-based review 
SEEN  Spanish Society for Endocrinology and Nutrition 
SelH, SelI SelK  selenoproteins H, I and K;  
SEP15  15 kDa selenoprotein gene;  
SEPP1  selenoprotein P gene;  
SES  socioeconomic status 
SF  serum ferritin 
SNP  single nucleotide polymorphism 
TNFα tumour necrosis factor alpha 
TNFαR2  tumour necrosis factor alpha receptor 2 
TrxR1-3  thioredoxin reductases 1-3;  
TSH  thyroid stimulating hormone 
UIE  urinary iodine excretion 
UL  tolerable upper intake level 
UNICEF  United Nations Children’s Fund 
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USI  universal salt idiosation 
UVB  ultraviolet blue 
VCAM  vascular cellular adhesion molecule 
VMNIS  vitamin and Mineral Nutrition Information Service 
WBC white blood cell 
WCRF/AICR  World Cancer Research Fund/American Institute for Cancer Research;  
WHO World Health Organisation 
WMD weighted mean difference 
Zn  zinc 
ABSTRACT 
The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence 
explored the process of setting micronutrient recommendations to address the variance in 
recommendations across Europe. Work centred upon the transparent assessment of nutritional 
requirements via a series of systematic literature reviews and meta analyses. In addition, the 
necessity of assessing nutritional requirements and the policy context of setting micronutrient 
recommendations was investigated. 
Findings have been presented in a framework which covers nine activities clustered into four 
stages: stage one  ‘Defining the problem’ describes activities 1 and 2: ‘ Identifying the nutrition-
related health problem’ and ‘ Defining the process’; stage two ‘Monitoring and evaluating’ 
describes activities 3 and 7: ‘Establishing appropriate methods’, and ‘Nutrient intake & status of 
population groups’; stage three ‘Deriving dietary reference values’ describes activities 4, 5 and 
6: ‘Collating sources of evidence’, ‘ Appraisal of the evidence’, and ‘ Integrating the evidence’; 
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stage four ‘Using dietary reference values in policy making’ describes activities 8 and 
‘Identifying policy options’, and ‘ Evaluating policy implementation’. These activities provide 
guidance on how to resolve various issues when deriving micronutrient requirements and address 
the methodological and policy decisions which may explain the current variation in 
recommendations across Europe. 
INTRODUCTION 
In Europe, micronutrient recommendations established by national and international committees 
of experts are used by public health-policy decision makers to monitor and assess the adequacy 
of the diets of population groups (Dhonukshe-Rutten et al., 2010a). There is no standardised 
approach for deriving recommended intake levels of micronutrients in Europe (Berti et al., 2010; 
Blanquer et al., 2009; King et al., 2007; Prentice et al., 2004). In 2007 the EC-funded Network of 
Excellence, European Recommendations Aligned (EURRECA) was established as a direct 
result of the socio-political climate in Europe and tasked with identifying the means by which to 
align micronutrient recommendations. Alignment includes the scientific content (objectivity, 
transparency, common basis), the processes to collate and summarise evidence, and the 
application of results by regional, national and international stakeholders who evaluate their 
policy options and implement the chosen applications (Dhonukshe-Rutten et al., 2010a). 
EURRECA has outlined what it considers to be the different stages that are core to the process of 
deriving and applying micronutrient recommendations:  
 Defining the problem 
 Monitoring and evaluating 
 Deriving dietary reference values 
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 Using dietary reference values in policy making 
Each stage consists of two or three activities (Figure 1) that those involved in deriving and 
applying nutrient recommendations need to consider.  
The first stage ‘Defining the problem’ (Activities 1 & 2) sets out the process by which dietary 
reference values will be set and includes defining the underlying problem to be addressed. 
The purpose of the second stage ‘Monitoring and Evaluating’ is to define appropriate methods to 
be used to estimate population nutritional health and identify groups at risk of malnutrition. It is 
needed throughout the process of both establishing micronutrient recommendations and their 
subsequent application in policy and practice. In this stage involving Activity 3 & 7 the intake 
and status of the micronutrient in question is monitored and evaluated.  
The stage ‘Deriving dietary reference values’ consists of three sequential activities (4, 5 & 6). It 
describes how a variety of sources of evidence can be collected, interpreted and integrated into 
average requirements in a harmonised and standardised way. From these, reference values for 
micronutrient intake for specified proportions of the population (resembling the definition of AR 
and PRI) can be derived. 
The stage ‘Using dietary reference values in policy making’ includes two activities (8 & 9) 
where policy makers identify appropriate policy goals and options and evaluate policy 
implementation. This stage then also, feeds back into the ‘Defining the problem’ stage.   
----Please insert Figure 1 here---- 
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THE EURRECA FRAMEWORK FOR DERIVING AND USING MICRONUTRIENT 
REQUIREMENTS 
Defining the problem: Identifying the nutrition-related health problem (Activity 1) 
At the beginning of the 20th century reference values addressed the nutrient needs for the 
prevention of deficiencies and related health problems. Currently, these health problems are not 
highly prevalent in the Western societies. There has been a shift in the way that dietary reference 
values are set which is more focused on the increasing prevalence of chronic disease. 
Increasingly, nutrient recommendations setting bodies now include optimal health and the 
prevention of chronic diseases when setting new reference values.  
Currently in Europe, however, only 10 countries included ‘prevention of chronic diseases’ in 
addition to ‘prevention of deficiency diseases’ in their definition of adequacy (unpublished work 
of EURRECA). The derivation of new or updated nutrient reference values should ideally be 
based on specific health outcomes related to functional capacities or the avoidance of disease. 
However, as convincing scientific evidence on the dose-response relationships between intake 
and health is often not available, other criteria of adequacy are used, such as subclinical 
nutritional health conditions identified by specific biochemical or functional measures, or 
requirements to maintain physiological balance. These markers are useful to the extent that they 
can be considered as intermediates in the pathway between nutrient intake and the ultimate 
health or disease endpoint. As a separate approach, the nutrient balance in apparently healthy 
subjects can be used as a starting point for setting recommendations; this refers to maintenance 
of stores, losses, tissue growth. Although this is a widely used approach in nutritional science, it 
is strictly speaking based on apparently healthy people, and will thus lead to estimates of 
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Adequate Intake (AI) rather than Average Requirements (AR) and Population Reference Intakes 
(PRI).  
Although similar concepts and definitions are used around the world for the different reference 
values, the exact terminology differs. Because of its European scope, EURRECA used the EFSA 
terminology (AR, PRI) for practical purposes of (dietary) reference values (DRVs), and the 
neutral UNU terminology where this was required from the scientific point of view (Median INL 
or INL50 corresponding to Average Nutrient requirement (ANR) or AR when the requirement 
follows a standard normal distribution; Individual Nutrient Level or INL97.5 for PRI) (King et 
al., 2007). The EURRECA network focused on the process of deriving the average requirement 
and its distribution. The average intake requirement (AR: Average Requirement) is based on the 
median of the intake-requirement distribution of individuals and defined as the intake sufficient 
to meet the requirements of 50% of a specific population group, and recommended intake values 
are in practice defined as the PRI, which denotes the intake sufficient to meet the requirements of 
the majority (~97.5%) of a specific population group.  
The ultimate choice of the health criteria will depend not only on the available scientific 
evidence but also on the actual public health situation and health goals of each specific country 
(Taylor, 2008). Scientists should provide policymakers with tools such as health criteria and their 
implications in order to make choices and set priorities. As a consequence of prioritising 
different health outcomes or the criteria for acceptable health outcomes, it is possible to have 
multiple average nutrient requirements for different functional outcomes. Nutrition and public 
health policymakers should then determine which level of adequacy is preferred or achievable.  
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Health outcomes considered in EURRECA 
EURRECA considered and reviewed the following health criteria in order to choose the health 
outcome: 
1. The occurrence of diet-related chronic disease or precursors of disease; these health criteria 
can be considered as “health outcome”. 
2. Clinical biomarkers of key biochemical micronutrient functions relevant to nutritional health 
status; these health criteria are briefly labelled as “status markers”. 
3. Nutrient balance; maintenance of body stores by adequate compensating obligatory losses 
and providing needs for reproduction and growth during the life cycle. 
EURRECA identified the most relevant health outcomes by determining the number of hits that 
emerged in preliminary searches of the literature combined with the opinion of scientific 
nutritional experts (see also Activity 6, Expert consultation). Supplementary table 1 shows the 
health outcomes studied for the micronutrients which were reviewed within the framework of 
EURRECA for different life-stage groups.  
Principally EURRECA covered two different concepts which are effective in order to derive  
reference values (King et al., 2007). They include the factorial approach and the dose-response 
approach which is illustrated in Figure 2 and which will be described in more detail in Activities 
4, 5 and 6. The final component, i.e. the formulation of recommended micronutrient intake for 
specific population groups is the outcome of both approaches together with a number of policy 
issues that are further detailed in Activities 2 and 8. 
----Please insert Figure 2 here---- 
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Population groups  
Definition of apparently healthy 
Reference values are designed for the planning and evaluation of a diet to keep populations 
healthy. This involves studying the association between intake, status and health outcomes. The 
question of what constitutes a healthy population has become more complex during the past 50 
years as a result of better understanding of health and chronic disease aetiology and because 
there is no overall definition or consensus (Sheffer and Lewis Taylor, 2008; Taylor, 2008). In the 
EURRECA network, apparently healthy was defined as the absence of diseases based on clinical 
signs and symptoms of micronutrient deficiency or excess and normal function as assessed by 
laboratory methods and physical evaluation (World Health Organization (WHO) and Food and 
Agriculture Organization of the United Nations (FAO), 2004). However, depending on the 
specific research question the exact definition of apparently healthy varied slightly, i.e. was 
tailored, in EURRECA’s research activities.  
Defining life-stage population groups  
As nutrition-related health problems may differ between population groups, it is important to 
identify and clearly define the population groups of concern. Within Europe, operational 
categories of age groups vary, especially for children, adolescents and elderly people (Doets et 
al., 2008). The age of transition from ‘adult’ into the ‘elderly’ category varied between the age of 
50 and 76 years. Moreover, some countries defined an additional category of ‘late’ elderly thus 
acknowledging the specific needs of a growing population group in Europe. Pregnant and 
lactating women are defined in almost all countries and some countries distinguished various 
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stages of pregnancy (usually according to trimesters, sometimes weeks) and pre-pregnancy. For 
some micronutrients, specific population groups are mentioned, i.e. post-menopausal and 
menstruating women (iron), sunlight exposed people (vitamin D) and smokers (vitamin C) and 
formula fed infants (calcium and zinc). The EFSA panel on Dietetic Products, Nutrition and 
Allergies (NDA) (EFSA, 2010) recently proposed to use nutrient-specific age ranges depending 
on the nutrient and the available scientific data to derive reference values. 
To define age groups three options were considered: 1) chronologic age, 2) physiological age; 
use of functional characteristics (e.g., growth and puberty), or 3) social age. These were all 
potential purposes for which the reference values might be used (e.g. complementary feeding 
programs). To avoid confusion EURRECA decided to use the same life-stage groups for all 
nutrients as proposed by the United Nations University (UNU) (Atkinson and Koletzko, 2007). 
Special attention must be paid to the needs of infants and the elderly (above 65 years) as they 
have a relatively high requirement of certain micronutrients per unit body weight and energy 
intake. 
Population groups considered in EURRECA 
Before the research activities commenced, EURRECA defined the following life stage groups 
when reviewing best practices and evidence for setting requirements:  
 infants (0-12 months: ~5 % of the EU27 populations),  
 children and adolescents (1-18 years: ~15-20% of the EU 27 populations),  
 adults (19-64 years: ~60% of the EU 27 populations),  
 elderly (65+ years: 15-20% of the EU 27 populations),  
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 pregnant women 
 lactating women  
These categories are in line with the population groups defined by the EFSA panel (2010).  
In addition to age and life cycle, other population grouping criteria used were related to 
physiological, biological and cultural factors. This included factors related to body size (such as 
height and weight, obesity, physical activity); and biological variation in needs further addressed 
in Activity 6.  
Finally, factors such as ethnicity and socio-economic status may be relevant to increased 
vulnerability to inadequacies resulting from limited access to nutritious foods. Health 
policymakers may decide to include socio-economic and political aspects in the context of 
surveillance of the actual micronutrient intake and status, and nutritional health problems in 
specific population groups. Therefore, in addition to the different age groups studied (from 
infants to elderly), EURRECA also addressed low income and immigrant status as potential 
determinants of inadequate micronutrient intake. (Activity 7). 
Micronutrients  
The prioritization of micronutrients 
Reasons for updating reference values vary from statutory obligations, discrepancies with other 
countries’ recommendations, health status or disease incidence through to the emergence of new 
science or lobbying from those within or outside the scientific advisory boards of the nutrient 
recommendation setting bodies (Dhonukshe-Rutten et al., 2010a). Reviewing and evidence-
based updating of micronutrient recommendations is, however, costly both in time and money. 
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EURRECA developed a simple systematic prioritisation process to decide which micronutrients 
to focus on first. This fits within the adoption of evidence-based decision making in public health 
recommendations and helps move the process away from sole reliance on expert opinion and 
towards thoughtful consideration of the total body of evidence. In this process, it is important to 
question whether there is enough evidence to warrant re-assessment of the current requirements. 
The process (schematically outlined in Figure 3) was guided by three main, content-related 
criteria for reviewing and revising micronutrient recommendations:  
a) Amount of relevant and functional, new scientific evidence available for a particular 
micronutrient for different life-stage population groups;  
b) Public health relevance of the micronutrient through measures of dietary inadequacy and 
disease burden for the different population groups, including vulnerable groups such as low 
income and immigrant population;  
c) Heterogeneity defined as between-country differences in current micronutrient 
recommendations in Europe.  
Although the three criteria were easily measurable and reproducible in a short time frame, 
eminence-based expert opinion was required to compensate for the lack of a comprehensive 
overview of micronutrient inadequacy in different population groups in Europe. Alternatively, a 
more thorough and time consuming process involving the same basic principles could evaluate 
more thoroughly the amount of new evidence, to identify new outcomes, and to provide 
additional information on dose-response relation such as described by Yetley et al (2009). 
----Please Insert Figure 3 Here---- 
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Micronutrients considered by EURRECA 
The above process was applied to a long list of 28 micronutrients provided to EURRECA by the 
EFSA Panel. Based on this process the micronutrients vitamin D, iron, folate, vitamin B12, zinc, 
calcium, vitamin C, selenium, iodine and copper were prioritised (Cavelaars et al., 2010). This 
priority list of micronutrients was further refined by factors such as (i) avoidance of duplication 
of work already started by other organisations e.g. vitamin D and calcium, and (ii) micronutrient 
expertise available in the network, and (iii) available resources within the EURRECA network. 
Therefore, EURRECA eventually focused on the following micronutrients: iron, zinc, folate, 
vitamin B12, selenium, and iodine. In summary, the selection process included evidence derived 
by a scientific protocol, whereas the other three criteria refer to driving factors in the socio-
political context, such as the efficient use of available expertise and financial resources. These 
process-related issues are further detailed in Activity 2. 
Defining the problem: Defining the process (Activity 2) 
Deriving DRVs and setting recommendations provides a tool for policy makers to set public 
health nutrition policy; thus, although the use of DRV ranges widely (e.g. in medical care, to aid 
development of policy options such as food labelling, towards food composition data), they are 
developed with policy purpose in mind. Public health nutrition policy has been variably 
conceptualised in terms of values and intentions with a public health nutrition outcome in mind 
(Lawrence, 2007), as a process of influence and power relevant to public health nutrition (Walt, 
1994) and as a decision relevant to food and nutrition (Margetts et al., 2004). Common to all 
these conceptualisations is recognition that public health nutrition policy includes a consistent 
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approach to a nutrition problem that can change over time; that it includes a statement of values 
and intentions; and that it is legitimised by authority of individuals, offices or organisations.  
Following the definition of the problem and the recognition of the public health nutrition 
dimension, any discussion about which policy option to adopt requires the establishment of the 
breadth and strength of scientific evidence on the relationship between micronutrient intake and 
health status (e.g. increased sodium intake links with increases in blood pressure); health status 
and health outcome (e.g. blood pressure links with coronary heart diseases); and micronutrient 
intake and health outcome (e.g. sodium intake and coronary and heart diseases). A summary of 
such evidence and the resulting micronutrient DRVs should ideally be conducted by an 
independent scientific advisory body (SAB) brought together for its (inter)national credibility 
and expertise relevant to the problem to be addressed.  
The EURRECA Network of Excellence examined the processes of establishing micronutrient 
DRVs and the present activity represents a summary of research to define this process, with a 
particular emphasis upon normative aspects of the workings of SABs. This has been done by 
bringing together the key findings from the following data collection activities (see Table 1).  
--Insert Table 1-- D
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The focus on three micronutrients across six European countries ensured development of 
contrasting case studies (N=18) in terms of historical context as well as current micronutrient 
recommendations-setting processes and nutrition policy decision-making. 
Scientific Advisory Bodies (SABs) 
Scientific advisory bodies (SABs) are groups through which expert advice enters the political 
process. They can be established institutions, short-term commissions, ad hoc and standing 
committees and informal networks of experts. Their key role is to feed technical 
recommendations into the policy development process (Morestin et al., 2010; Timotijevic et al., 
2011a). The type of SAB varies by its statutory and legal role. EURRECA work has identified a 
diverse institutional architecture of SABs for nutrition operating across Europe including 
scientific advisory committees (SAC, often called “advisory councils”); public health institutes 
and research centres; nutrition societies and individual experts (Timotijevic et al., 2011a).  
Evidence suggests that SABs play a crucial role in advising government on development and 
implementation of nutrition policies in Europe: WHO have noted the possible link between the 
existence of SABs and the degree to which nutrition policies are developed and implemented 
(Trübswasser and Branca, 2009). Extending this work, EURRECA case studies examined the 
extent to which the type of SAB influences policy options recommended and showed that the 
likelihood of adopting regulatory micronutrient policies (e.g. mandatory fortification) does not 
vary by type of SAB. Nevertheless, it upholds the findings (Trübswasser and Branca, 2009) that 
the existence of a dedicated Scientific Advisory Committee is linked with a greater public health 
nutrition orientation of policy champions and a more evolved nutrition policy landscape – both 
institutionally and politically (Timotijevic et al., 2011a; Timotijevic et al., 2011b). Thus, 
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although costly, establishing such a committee (if it is not present already) is an important step 
towards transparent micronutrient DRVs. 
EURRECA work suggests that, before setting up such a committee, a careful deliberation about 
the terms of reference is required. This will determine substantial aspects of the workings of the 
SAB: the composition and purpose of the committee; the scientific and normative aspects of 
decision-making both within the committee (e.g. the criteria for assessing scientific evidence and 
making conclusions) and beyond it (e.g. how to deal with stakeholder comments). The terms of 
reference must be specific enough to enable identification of appropriate expertise. Nevertheless, 
a degree of autonomy should be granted to the SAB to define the problem in a way that enables 
it to work within the realm of the existing knowledge. This definition should be explicit about 
how uncertainties and assumptions will be dealt with (Timotijevic, in prep.-b). 
SAB composition 
There are many ways to identify suitable expertise for a SAB relevant to micronutrient 
recommendations. Individual expertise, institutional authority, representation of a sector and 
representation of different types of knowledge are common and often overlapping criteria for 
selection. In some cases, the decision about who will be invited is made by the standing SAC 
(e.g. the UK) (Timotijevic et al., 2011a), whilst in others, the policy maker engages in 
recruitment of suitable expertise (Timotijevic et al., 2011a). Identifying the right skills/expertise 
mix and the appropriate experts is a complex process often criticised for lack of transparency and 
bias (Bijker et al., 2009). The selection of SAB experts should ideally follow a protocol, both in 
terms of disciplines represented but also in terms of what counts as “expertise” (Timotijevic et 
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al., 2011b). In addition, key to recruiting experts into SABs is to ensure that conflicts of interests 
are dealt with appropriately. Requirement for the expression of conflict of interest is not only a 
route to transparency but also to ensuring legitimacy of a SAB’s decision by removing the 
questions of decision bias. In reality, however, expertise relevant to specific micronutrients may 
be scarce and access to it may be further limited due to the increased pressures (through research 
funding policies) upon scientists to engage in “impactful” research by collaborating, for example, 
with industry (Rockey and Collins, 2010).  
The type of expertise (in terms of the disciplines represented at the SAB) involved in setting 
micronutrient DRVs for a single micronutrient and the type of body involved (based on its 
statutory role) varies widely across Europe (Timotijevic et al., 2011a). Based on the Europe-wide 
survey of the process of setting of micronutrient recommendations conducted by EURRECA 
partners, we can conclude that most countries mention at least three of the following fields of 
expertise: nutrition, (public) health, medicine, biochemistry, food technology, epidemiology, 
food hygiene and toxicology (Table 2). In several countries (e.g. UK) as well as at the European 
level, lay or consumer representatives are included in the SAC or the working groups. The way 
in which expertise is defined and SAB are structured, determines how a problem is framed, 
which in turn influences the decisions around the inclusion or exclusion of particular 
perspectives and the way in which facts are selected and interpreted and conclusions are drawn. 
The nature and source of expertise may also be significant factors in whether scientific advice is 
taken up in the policy-making process. Such diversity appears to reflect a) the diverse “terms of 
reference” presented to the SAB; b) the extent of the public health nutrition orientation within 
the country including the way it is institutionally embedded (e.g. see table 2 OR 3)  – that is,  
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how central and explicit the public health nutrition agenda is to the national health policy 
(Jeruszka-Bielak, in prep.); c) the scientific resources, i.e. the development of science, the range 
of technical expertise available (Timotijevic, in prep.-a); d) the broader societal engagement (e.g. 
institutions other than government and the public at large) with the generic problem of public 
health nutrition; e) the financial resources (Timotijevic et al., 2011a). 
----Please Insert Table 2 Here---- 
 Stakeholder involvement and normative decision-making 
Whilst there are many frameworks for collating and interpreting scientific evidence, the 
protocols for how to deal with the normative aspects of decision-making that include issues of 
disagreement between scientists (on matters of nature of evidence, interpretation of evidence and 
implications of the evidence for public health and/or policy), consultations with stakeholders on 
matters under discussion within SAB, and how to respond and take on board stakeholder 
submissions to consultations, are scarce yet critical, as EURRECA work has shown (Timotijevic 
et al., 2010b; Timotijevic, in prep.-b) Wider involvement in decision making of SAB is called 
upon by a range of EU policy documents (e.g. Science in Society Action Plan (European 
Commission, 2001a, c); Communication on Collection and Use of Expertise (European 
Commission, 2002), as it is thought to increase transparency and accountability, improve quality 
of decisions and contribute to the democratic capital of the decision-making body and science 
governance. For instance, EFSA specifies the following steps for consultations: the draft report is 
put up for public consultation for at least 60 days during which opinions are collected (mostly in 
written format) and considered. EFSA typically produces response to consultation where it 
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justifies the way the comments have been incorporated into the report, usually within 3 weeks 
from receiving the comments.  
However, we know little about how this evolves in practice even when consultations are 
conducted publicly and posted online. The role of stakeholder consultations within the workings 
of SAB is of particular relevance in the context of recent questions about the utility and ethics of 
such an endeavour. For instance, in the UK, there have been increased calls for scientific 
independence from vested interests (which stakeholder consultation can act to obscure) 
(Government Office for Science, 2009). Similarly, recent academic literature has shown that 
stakeholder consultations are particularly problematic in the domain of science where vested 
interests seek to influence decisions (Bijker et al., 2009), such as the case of  sodium.  
EURRECA have conducted research in this domain and tried to describe the processes of 
stakeholder consultations where they are actively endorsed. Where stakeholder consultation is 
explicitly permitted, (it is with an aim of: a)  identifying  relevant evidence to take into 
consideration and/or b) as a way of getting feedback on draft reports in preparation for a final 
report. These consultations are usually written communiqués that invite comments from relevant 
stakeholder groups. It is at the SABs discretion as to whether to engage with these comments, 
thus upholding the principle of scientific autonomy. Nevertheless, the Eurreca examination of the 
2 cases of stakeholder involvement (UK SACN and EFSA) shows that it is not always made 
explicit how different stakeholders’ contributions are weighed for their relevance and what 
mechanisms are in place to ensure that stakeholder comments are reflected in the decisions. 
There is limited information about the procedures in place to simultaneously manage the 
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potentially contradictory rationale for scientific independence and stakeholder involvement 
(Timotijevic et al., 2011b; Timotijevic et al., 2010b), which places an added pressure upon the 
SABs to engage in a complex manoeuvring of the often  irreconcilable objectives of 
independence and engagement.  
----Please Insert Table 3 Here---- 
Risk assessment and risk management 
The EURRECA case studies (please see (Timotijevic et al., 2013) for information about the 
methodology employed in the case studies) have demonstrated that the purpose of a SAB for 
Nutrition will be partly premised upon definition of the problem, but also partly upon the 
regulatory context and the existing nutrition policy objectives (Timotijevic, in prep.-a). Thus for 
instance, there is often an explicit call for the clear much of the activity of dietary modelling and 
nutrient recommendations setting within the framework of risk analysis (or RAF, 
(MacKerras,2012)). The key feature of RAF is an explicit separation between risk assessment 
and risk management (as is the case with EFSA and the UK SACN, whereby the SAB activity is 
often delimited as a risk assessment exercise) deemed necessary in order to as a way of achieving 
a clear demarcation of demarcate accountabilities and modes of operation between scientific and 
political actors. But this may not always be possible due to, for instance, institutional 
characteristics of the public health nutrition policy (the institutional contexts within which policy 
is developed differ across countries, see Table 2 OR 3 and Figure 20 for examples of the types of 
organisations involved in the process), nor ideal as a way of achieving optimal public health 
nutrition policy. At the institutional level, researchers have shown that risk assessment is 
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inextricably bound with social and political context, power relations and practices (Bieirle, 1990; 
Wynne, 2003) which makes demarcation of risk assessment and management difficult to uphold. 
There are calls for greater transparency  about the processes of risk assessment (and about the 
instances when risk assessment is partly premised upon political realities), however this may also 
have a possibly unintended consequence of selective transparency, whereby SAB members make 
explicit only those aspects of risk assessment that are characterised by scientific consensus 
(Walls et al., 2010).  
 Communicating findings to policy decision-makers 
SABs review evidence of associations between micronutrient intake, health status and health 
outcome to derive micronutrient DRVs, and in some cases also provide recommendations about 
selection and suitability of a policy option (e.g. mandating for food fortification with a 
micronutrient, (Dhonukshe-Rutten et al., 2010b; Timotijevic et al., 2010b). For a policy option 
based on micronutrient DRVs, evidence needs to be established of the risks as well as benefits, 
e.g., risk of overconsumption. Clear protocols for selecting, weighing and interpreting evidence 
are a norm across the EU and are in line with the principles of conducting scientific research 
(Brown, in prep.). Such protocols (for instance the ‘SACN Framework for the Evaluation of 
Evidence’ (Scientific Advisory Committee on Nutrition, 2011) or ‘A Guide for Conducting 
Systematic Literature Reviews for the 5th edition of the Nordic Nutrition Recommendations’ 
Nordic Council of Ministers, 2011 (NNR5 working group, 2011)) structure the decision-making, 
act as guidance and ensure transparency about the final recommendations. However, even with 
the existence of such protocols, the evidence base is complicated by several factors, including 
great variation in the terminology used for micronutrient requirements and heterogeneity of 
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recommended micronutrient values; variations in definition of population groups and the various 
approaches to establishing micronutrient requirements (for more information please see 
Activities 1,3,4). This is certainly a challenge to both the SAB and the policy makers and it is 
critical that these assumptions are made explicit in communicating conclusions to policy makers. 
Nevertheless, there is also an intrinsic problem in communicating uncertainties and assumptions 
to policy makers particularly in the context of policy areas that often lack explicit political 
support and prioritisation, such as public health nutrition.  
The way in which the SAB conclusions are communicated to policy makers is sometimes a 
significant hindrance to the way science informs and ultimately influences policy. Scientific 
activity is characterised not by pursuit of the ultimate truth (or the final proof) but to the 
contrary, by the efforts to disprove the hypotheses as falsifiability (the potential to disprove the 
hypothesis) is an essential criterion of scientific method. As such, scientific endeavour is based 
upon the implicit acceptance of uncertainty. Policy however is often communicated through 
statements of certainty and hence policy makers seek assurances of certainty from scientists that 
would give credibility and ensure effectiveness of the policies they mandate. There is a general 
agreement that scientific and technical knowledge can improve policy as it is understood to be 
committed to addressing and communicating best available evidence to decision-makers 
(Timotijevic et al., 2011b). How this evidence is to be relayed to the policy maker, however, is a 
moot point. The key is to identify a way of communicating the nature and the degree of 
uncertainty that paints an appropriate picture of the state of knowledge in the scientific 
community and the extent to which such knowledge can be relied upon to derive optimal 
solutions. It is widely accepted that communicating uncertainties is beneficial not only from the 
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normative point of view (since openness about the nature of knowledge is a key value in our 
society and increases trust), but also has an instrumental value (as it can help derive the best 
policy). However, communicating uncertainty can also be a deterrent to a policy maker who 
seeks assurances from science in contexts characterised by controversies and vested interests. 
SABs must therefore be aware of this conflict and reflectively deal with those in the process of 
communicating DRVs and the associated assumptions/uncertainties. 
Monitoring and evaluating: Establishing appropriate methods (Activity 3) 
Understanding the function, physiology and biochemistry of a micronutrient is essential for the 
accurate derivation of dietary requirements. In the case of micronutrients with no sensitive or 
specific biomarker of status, understanding the physiology and biochemistry may provide insight 
with the use of –omics technologies to identify potentially novel indicators of status. The 
EURRECA network has summarised the function, physiology and biochemistry of a set of 20 
micronutrients in the Best Practice Guidelines: Biomarkers of status/exposure (Harvey et al., 
2011). Whilst the principal functions of the majority of micronutrients are well-characterised, it 
should be acknowledged that it is vital to explore the most recent data for newly identified 
physiological roles as compared with previous estimations these may seriously impact on the 
derivation of dietary requirements in some or all population groups.  
In practice the above translates into the identification of robust data for both dietary intake and 
status. These data, and their inter-relationships, in conjunction with those for relevant health 
outcomes, facilitate the determination of dietary requirements for specific population groups 
(Matthys et al., 2011). Selecting the most robust methodology available to assess dietary intake 
and status maximises data reliability; however the choice of technique may be influenced by the 
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analytical environment e.g. studies in the field may impose practical limitations compared with 
laboratory-based research. As a result EURRECA has endeavoured to identify current best 
practice for assessing micronutrient intake and status (Fairweather-Tait and Harvey, 2008; 
Fairweather-Tait et al., 2009; Serra-Majem, 2009a; Serra-Majem et al., 2009b) and has collated 
relevant information useful for deriving individual micronutrient requirements. Ideal methods for 
assessing both dietary intake and status are not always available; therefore, best practices have 
been developed for identifying robust dietary assessment instruments relevant to harmonising the 
science of estimating micronutrient intake and nutritional adequacy in Europe (Serra-Majem et 
al., 2009b).  In addition, computer-assisted training tools for the validation and calibration of 
such dietary assessment instruments have also been developed by the network (Busstra et al., 
2010; Noroozi et al., 2012) and demonstration material is available on the EURRECA website 
(www.eurreca.org/everyone/8321/7/0/32 and www.eurreca.org/Courses/demo/index.html). 
Regarding biomarkers, the EURRECA network provided a platform on which the use of -omics 
techniques to identify novel data related to inter-individual variability could facilitate the future 
identification and development of new biomarkers of micronutrient status (van Ommen et al., 
2008). 
 Assessment of dietary micronutrient intake   
Establishing accurate dietary micronutrient intakes to allow valid comparison between 
population groups and evaluate changes in nutrient intake over time requires the use of rigorous 
methodology which may be micronutrient specific. A summary of the main problems and issues 
associated with dietary assessment is reported in Matthys et al. (2011). EURRECA has 
established best practice for dietary assessment of the European population through undertaking 
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a series of systematic reviews (Serra-Majem, 2009b; Serra-Majem et al., 2009b). The reviews 
covered a range of topics related to micronutrient intake focusing on specific population groups 
outlined in Activity 1, where intake assessment is acknowledged to be particularly challenging, 
and highlighted the potential use of new methodologies to increase accuracy. Reviews were 
undertaken to establish the best and most commonly used methods for assessing nutrient 
adequacy, including the consideration of dietary patterns in the context of European populations. 
Evaluation of the strength of various methodologies was undertaken by appraising the magnitude 
and origin of measurement errors. Specific aspects of research undertaken by the EURRECA 
network are considered in more detail in the following sections. 
Diversity in dietary assessment methods 
The choice of dietary assessment methodology will depend on various factors including study 
design and the associated practicalities of conducting the research, along with the explicit aims 
of the study being undertaken. No method is free from random or systematic errors, or prevents 
subjects changing their food habits. Specific factors that need to be considered when choosing a 
method are the characteristics of the subjects within the study population e.g. life stage, or 
immigrants and low income groups etc., the respondent burden of the method, and the available 
resources. Some methods may be unsuitable for elderly subjects with poor memory, busy adults 
with young children or those individuals with poor reading skills. Other methods require 
specialised equipment and computer facilities or highly trained personnel. The most accurate 
methods are generally the most costly with greatest respondent burden and ultimately lower 
response rates (Gibson, 2005). For nutrition surveillance studies, for example, the standard is to 
use replicates of 24 hour recalls whereas for proof of principle studies on the relation between 
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dietary intake and health outcomes FFQ-like methods are  the standard. The latter have, though, 
very different measurement characteristics that prohibit direct comparability and necessitate 
validation and calibration approaches when appropriate. 
In a study undertaken by the EURRECA network, the risk of dietary inadequacy was found to be 
dependent on a combination of the dietary assessment methodology employed and the 
micronutrient being assessed (Ribas-Barba et al., 2009). More specifically, it was evaluated how 
applying different dietary methods affects risk assessment of inadequate intakes at the population 
level and it was revealed that the prevalence of inadequate intake decreased in conjunction with 
the method utilised in the following order: single 24hour, mean of two 24hour recalls, FFQ and 
usual intake based on 24hour recall duplicates adjusted for within subject variation.  For 
example, the effect of utilising two non-consecutive 24hour recalls when compared with a single 
24hour recall showed a slight decrease in the prevalence of inadequate intakes for the majority of 
nutrients. In the majority of cases, but not all, methods that measured usual intakes i.e. 
retrospective food pattern methods such as food frequency questionnaires (FFQ) or diet histories, 
identified lower values of inadequacy than those obtained by quantitative daily consumption 
methods including 24hour recalls. The study also assessed the impact of underreporting on the 
levels of dietary inadequacy (Ribas-Barba et al., 2009). As expected, the exclusion of under-
reporters led to a decrease in the prevalence of dietary inadequacy; however this has again been 
shown to be micronutrient and methodology dependent.  
Assessment of food intake is challenging and prone to reporting error, especially among infants, 
children, and adolescents. A review conducted by the EURRECA network attempted to assess 
whether FFQs are suitable for the evaluation of micronutrient intake adequacy in infants, 
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children and adolescents (Roman-Vinas et al., 2010).  For several micronutrients the results of 
the review highlighted a lack of sufficient data to assess the usefulness of FFQs to provide robust 
estimates of intake. In addition, it was noteworthy that very few potentially relevant validation 
studies in children incorporated the use of status biomarkers, which for some micronutrients may 
provide a surrogate measure of intake. Consequently, the review identified the requirement to 
undertake further research to address specific concerns related to FFQ validation in infants, pre-
schoolers, children, and adolescents, particularly with regard to irregular patterns of intake (small 
portions, snacking) that is prevalent in these population groups. 
Whilst dietary assessment of populations frequently attempts to obtain reliable information on 
supplement use, establishing accurate intakes is generally difficult. A true picture of intake can 
only be ascertained if regard is paid to supplement consumption patterns, the numbers of non-
consumers, those with sporadic consumption in times of illness and those who take supplements 
on a regular basis (Ribas-Barba et al., 2009).  
Quality scoring of dietary intake data 
Evaluating the quality of dietary micronutrient intake assessment is vital to ensure the validity of 
data that may be used in the process of establishing dietary reference values. Following 
EURRECA’s in depth review of all available dietary assessment validation studies, which 
analysed the utility of a range of dietary micronutrient intake questionnaires (Henriquez-Sanchez 
et al., 2009; Ortiz-Andrellucchi et al., 2009a; Ortiz-Andrellucchi et al., 2009b; Ortiz-
Andrellucchi et al., 2009c; Øverby et al., 2009; Serra-Majem et al., 2009c), it was concluded that 
a scoring system was required to facilitate straightforward evaluation of the reliability of FFQ 
data (Serra-Majem et al., 2009a).  
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A scoring system was developed as a three step process; step 1 considered variables such as 
sample population and size, statistics (group level, correlations, agreement), type of data 
collection, seasonality and supplements. Scores ranged from 0 to 7, and validation studies were 
classified as very good (≥5), good (5–3·5), acceptable/reasonable (3·5–2·5) and poor (<2·5). The 
second and third steps included an adjustment/weighting of the correlation coefficient according 
to the quality score in addition to a rating of the adjusted/weighted correlation. The 124 
validation studies assessed, which reported data from at least one vitamin were also categorised 
into three groups dependent on the reference method or gold standard applied in each case. The 
overall results highlighted that only 5.6% of the studies were rated as very good quality whereas 
16.9% had a poor rating. Despite the fact that the model weighs for several methodological 
variables, the reference methods can also contain some bias and therefore the authors cannot rule 
out remnant bias in the final model. However, this evaluation tool could be used as guidance for 
studies validating dietary intake questionnaires or to assist researchers select and weigh the 
results of existing epidemiological studies; in both cases, its use can ultimately contribute to 
increasing the quality of evidence in nutrition research (Serra-Majem et al., 2009a).  
Use of a whole-diet approach (using dietary patterns) 
It is increasingly recognised that as foods and nutrients are not consumed in isolation, the 
combination of possible antagonistic and synergistic effects between dietary components is 
likely to have a significant impact on health. The likelihood that overall dietary patterns 
potentially have a greater effect on health than any single food or nutrient (Jacques and Tucker, 
2001) probably explains the pathogenesis of many chronic, nutrition-related diseases and in 
addition the health benefits derived from diet. Consequently, there has been a gradual shift away 
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from assessment of single nutrients and foods towards the evaluation of whole diets and dietary 
patterns, particularly in relation to nutrition and health (Hu, 2002; Kant, 2004). Assessment of 
dietary patterns can provide valuable data on disease prediction and may facilitate investigations 
on interactions between intake and other health behaviours, or diet and other confounders of 
exposure-disease relationships. Dietary pattern analysis is also useful in the monitoring and 
surveillance of populations with regard to dietary trends and compliance with food-based dietary 
recommendations, and consequently is highly relevant to policy aspects of DRV setting 
discussed further in Activity 8. 
The various methods used to characterise dietary patterns within a population generally fall into 
two categories. The first category involves a priori evaluation (hypothesis-oriented) using score 
based approaches, whilst the second relies on a posteriori analysis using data-driven dimension 
reduction techniques, such as principal components analysis (empirically-driven) (Dixon et al., 
2001; Hu, 2002; Kant, 2004; Michels and Schulze, 2005; Newby and Tucker, 2004; Roman-
Vinas et al., 2009; Sánchez-Villegas and Serra-Majem, 2005). Whilst rare, some studies have 
combined both types of approach (Wright et al., 2004). However, there is generally little 
consensus on which approach to employ in various circumstances. Consequently, the EURRECA 
network addressed this issue in relation to pregnancy and maternal and infant health outcomes. A 
systematic review was undertaken in this population group to review the literature exploring 
associations between dietary patterns obtained from FFQs and relevant health outcomes 
(Sánchez-Villegas et al., 2010). Of the seven relevant studies identified, only four employed 
questionnaires specifically validated for use in pregnant women and the use of differing 
analytical techniques made data comparison difficult. However, the review concluded that whilst 
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using appropriately validated FFQs was essential, specific consideration should also be given to 
mineral and vitamin supplements and the timing of data collection in this population group. In 
addition, results should be adjusted for lifestyle and educational characteristics, and any a priori 
evaluation requires appropriate selection of scoring components. 
Data selection 
As a result of the culmination of a series of reviews and activities undertaken by the EURRECA 
network (described above) with respect to the assessment of dietary micronutrient intake in the 
European population, consensus was reached and best practice guidelines (Claessens et al., 2013) 
were developed to enable identification of the most robust intake data that would be relevant for 
the derivation of DRVs (Garcia-Alvarez et al., 2009). Specifically, a decision tree was developed 
which facilitated the screening and selection of appropriate studies for inclusion in the meta-
analysis of intake-status-health relationships for a series of priority micronutrients. The 
aforementioned EURRECA systematic reviews were comprehensive in nature and only included 
studies of the utmost quality. Whilst development of the tool was originally for a specific 
requirement, it may also be used generically in the evaluation of intake data from a range of 
studies and for a variety of purposes. The original tool that was developed consisted of a twenty 
question scoring system, and whilst rigorous and robust, it proved unwieldy to utilise in the 
evaluation of significant numbers of studies. As a consequence, a honed version of the scoring 
tool was developed in the form of an abbreviated decision tree (version 1), which was 
subsequently further refined into a less restrictive tool (version 2) (Figure 4). In the final version, 
each study is taken through a series of seven questions which allow the user to evaluate the 
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robustness of dietary intake data enabling the identification of data of the required standard (data 
to ‘include’) which may ultimately be used in the derivation of DRVs.  
In addition, one of the key achievements of EURRECA in relation to dietary intake assessment 
was the development of a best practice guide for the identification of quality surveys for nutrient 
intake adequacy assessment in populations on a country by country basis. A step-by-step set of 
guidelines which summarised the process developed to select the ‘best’ or the ‘highest quality’ 
dietary survey/study in each country is shown in Figure 5 (Garcia-Alvarez et al., 2009). These 
guidelines were developed to increase comparability of the dietary data obtained. The 
methodology is a two-step process, with the first phase consisting of the identification of the 
most appropriate survey in each country. It was determined that ideally, selected surveys should 
focus on nutrition, however in their absence the second choice should be health surveys 
including nutritional data, or lastly household budget surveys with nutritional data. Briefly, the 
best practice criteria for identifying surveys in this initial phase were as follows:  
 Data should be collected through use of a standardised instrument 
 Only one survey/study per country can be considered 
 Surveys/studies of cross-sectional nature 
 The most representative survey/study of the country’s population (to maximise external 
validity) – ideally at the national level (otherwise regional or, lastly, local levels) 
 The most recent surveys/studies (only include those conducted after 1990) 
 Surveys/studies with the best methodology in accordance with their objectives (to maximise 
internal validity) 
----Please Insert Figure 4 Here---- 
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Following identification of appropriate surveys it was established that a quality scoring system 
should be applied in the second stage of the evaluation process. The six variables considered in 
the quality analysis stage, in priority order, are dietary assessment methods, validation, food 
composition databases, under-reporting, other factors including anthropometric measurements, 
physical activity etc., and finally the year the survey was conducted.  
In order to test the validity of the Best Practice Guidelines on Nutrient Intake Assessment, 
following requests from the EURRECA network, 29 out of 32 countries (28 European and four 
European Free Trade Association countries) responded to questionnaires requesting information 
on national surveys, which ultimately resulted in suitable data being identified from a total of 24 
studies/surveys of the adult population (Blanquer et al., 2009). The resulting analysis of the data 
established that the best practice guidelines form an appropriate strategy, which can be adopted 
for the identification of the best cross-sectional dietary intake data available (Garcia-Alvarez et 
al., 2009). 
----Please Insert Figure 5 Here---- 
Assessment of micronutrient status 
Examples of types of status biomarkers include plasma concentration, size of body pools, 
enzyme levels and activities, urinary excretion and a range of other biochemical and/or 
functional indicators which have varying degrees of specificity and sensitivity. However, a more 
integrated approach to the assessment of micronutrient status would ultimately involve 
measurement of multiple biomarkers that are key components central to the maintenance of 
health, metabolic, oxidative, inflammation and psychological processes. These intermediary 
markers of metabolism could therefore be considered as surrogate markers of nutritional status. 
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Novel analytical methods, including nutrigenomics, metabolomics, and proteomics, have been 
applied by the EURRECA network to assess these markers (Bouwman et al., 2012; van Ommen 
et al., 2009). An example of a metabolomics approach to assess micronutrient related health 
status is described in the micronutrient specific sections on selenium (Hurst et al., 2013). There is 
a well-established need to develop improved biomarkers of status for many micronutrients, and 
the EURRECA network embraced network biology and nutrigenomic technologies in an attempt 
to progress the development of novel approaches that will ultimately facilitate the derivation of 
more accurate and specific dietary requirements and recommendations. 
The EURRECA network undertook a rigorous process with the aim of identifying and evaluating 
biomarkers of micronutrient status, which culminated in the production of a set of Best Practice 
Guidelines (BPG) of micronutrient status (Harvey et al., 2011).  The BPGs were initially 
conceived by the Biomarkers of Status Working Party, which comprised a group of international 
micronutrient experts and EURRECA partners who met in Norwich, UK in early 2008. 
Publication of the workshop proceedings (Fairweather-Tait and Harvey, 2008), included articles 
on several micronutrients where the authors critically reviewed traditional biomarkers employed 
in surveys, and the development of a network biology model of micronutrient related health, 
which may be utilised in future dietary guidelines. In addition the working party also produced a 
table of Biomarkers of Status and Exposure: Minerals and Vitamins, which consisted of a non-
exhaustive list of micronutrients for which dietary reference values have been produced. The 
table included a brief description of biomarkers of status and/or exposure for each micronutrient, 
accompanied by a rating of the methodological limitations and its application in research 
(suitable for research only and/or for fieldwork). A star rating (3* = excellent) was used to 
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classify the biomarkers, and a summary of available 3* indicators for selected micronutrients is 
available (Matthys et al., 2011). As the original remit was to assess biomarkers relevant for use 
in epidemiological studies, the EURRECA network has generally focused on the use of 
biochemical markers that can be obtained from blood or urine, rather than functional (e.g. 
immune function, cognitive function) and non-specific tests (e.g. grip strength).The table was 
subsequently updated to include data obtained from a series of systematic reviews undertaken by 
the EURRECA network, which focused on a selection of micronutrients with either public health 
significance, or a strong scientific requirement to establish the validity of status biomarkers 
(Biomarkers of Status Working Party, 2011) (see Evidence-based assessment of potential 
biomarkers). 
Finally, at the end of the review process the BPGs were produced for a non-exhaustive list of 
micronutrients for which dietary reference values had been produced, and included data from the 
EURRECA systematic reviews along with the expert opinions of the working party (Harvey et 
al., 2011).  The BPGs provide a basic introduction to various aspects of intake, function, 
metabolism etc, along with details of relevant biomarkers of status or/and exposure for each 
micronutrient.   
Evidence-based assessment of potential biomarkers of micronutrient status 
Understanding the relationship between micronutrient status and health can only be achieved by 
using robust biomarkers of status. In order to establish the validity of status biomarkers and 
identify the circumstances in which they may be relied on in terms of population groups, 
deficient or replete states etc., the EURRECA Network undertook a series of systematic reviews, 
focusing on a selection of micronutrients with either public health significance, or a strong 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 39
scientific requirement. Systematic reviews of biomarkers of status were conducted for vitamin 
B12, zinc, iodine, copper, riboflavin, magnesium, vitamin D, polyphenols, n-3 long chain 
polyunsaturated fatty acids and selenium (Fairweather-Tait et al., 2009; Pérez-Jiménez et al., 
2010; Witkowski et al., 2011). A common review methodology was developed on the basis of 
identifying studies that altered micronutrient status, with a subsequent pooling of the data for 
each specific biomarker (Hooper et al., 2009). Inclusion criteria were tailored for each 
micronutrient depending on the quantity and quality of available data. If sufficient data were 
available included studies were restricted to randomised controlled trials (RCT), but where there 
was a paucity of data both before-after and nonrandomised controlled trials were also included. 
Inclusion criteria also took into account the form of supplement used in the study and the 
minimum duration of intervention (supplementation or depletion) required to elicit a response in 
the biomarker following a change in status. The highest dose and longest duration intervention 
data were selected to statistically analyse biomarker validity. Studies were sub-grouped by 
population, dose, duration, sex, supplement type and analytic method as appropriate in order to 
assess the consistency of response for each biomarker.  
Use of this methodology highlighted specific micronutrients where a plethora of data allowed 
evaluation using data almost solely obtained from RCTs e.g. vitamin D (Seamans and Cashman, 
2009), and others where there was a lack of suitable RCT studies, and consequently evaluation 
had to be undertaken using lower quality data e.g. copper (Harvey et al., 2009). In addition to 
demonstrating the usefulness of systematic review methodology to validate the use of biomarkers 
of status for a range of micronutrients, it has also highlighted the need for further research to 
identify and evaluate novel biomarkers of micronutrient status. 
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Biomarkers for micronutrient related physiological processes 
To date, significant emphasis has been placed on researching the biological activity of single 
micronutrients, or interactions between limited combinations of micronutrients. However, with 
the development of a systems biology approach, the potential to study the multiple processes that 
collectively underpin molecular, cellular and whole body physiology may enable an integrated 
perspective to be taken with regard to the impact of metabolic effects on health (van Ommen et 
al., 2008). The EURRECA network undertook research to establish novel approaches that may 
be applied to the assessment of micronutrient status in relation to health. Apart from established 
biomarkers micronutrient status may also be assessed by measuring health status biomarkers 
reflecting processes that require sufficient micronutrient availability. Therefore, information on 
the effects of micronutrient intake and/or status on selected biomarkers related to the overarching 
metabolic, inflammation and oxidative processes, was extracted from studies that were included 
based on the criteria described above (see Evidence-based assessment of potential biomarkers). 
This information was captured by the EURRECA network in collaboration with the European 
Nutrigenomics Organisation (ENO) on the respective micronutrient pages of the ‘NuGOwiki’ 
(European Nutrigenomics Organisation, 2012, www.nugowiki.org), an open source ENO 
database where anyone can edit / add information in a typical wiki manner (mediawiki) 
(Claessens et al., 2013).  To fully appraise the impact of micronutrients on health, a more holistic 
view of the biological effects of multiple micronutrients is needed, including building 
micronutrient-centered biological networks (van Ommen et al., 2009) and developing suitable 
statistical methods for assessing individual micronutrient-health effects (Activity 6: ‘health 
space’ model) (Bouwman et al., 2012). 
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Evidence of the direct or indirect effects of individual micronutrients on selected biomarkers for 
key physiological processes (immune, oxidative and metabolic process) is captured on the 
micronutrient pages of the NuGOwiki (www.nugowiki.org/). Micronutrient-centered biological 
networks prepared from extensive literature mining for selenium, vitamin B12 and folate, are 
also publicly available (www.wikipathways.org). For the purpose of deriving micronutrient 
requirements, where there are known interactions, it may be useful to investigate and define the 
complex micronutrient biology network based on micronutrient markers, markers of target 
function and biological response, micronutrient related health status metabolites and 
micronutrient related disease parameters.  
As an example of this EURRECA approach, information collated from human studies that met 
the above-mentioned selection criteria (NuGOwiki micronutrient portal, 
http://www.nugowiki.org/) was used to construct micronutrient biology network models. As an 
example, the mathematical model for the multiple micronutrient dependency of the inflammatory 
process can be found in Supplemental Figure 1.  
Deriving dietary reference values: Collating sources of evidence (Activity 4) 
There is significant disparity in the evidence base for micronutrient recommendations between 
population groups (Dhonukshe-Rutten et al., 2010a). Figure 6 conceptualises average 
requirements (AR) for micronutrients as a function of age (population group and age across the 
life cycle), and highlights the widely different types of evidence and research approaches that 
underlie these data. RCTs and epidemiological studies provide evidence for the adult population 
group on optimal nutrition in relation to specific health outcomes and end points; whilst factorial 
approaches, combined with estimates of bioavailability, are generally used during periods of 
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growth and development. In order to derive reliable recommendations the most robust data need 
to be identified and integrated, whilst accounting for exercise and body composition and size 
(scaling). As illustrated by this Figure, identifying and collating relevant data for the derivation 
of dietary recommendations should ideally be undertaken using a clearly defined systematic 
approach which accounts for the micronutrient, the population group, and the health 
outcome/end point under assessment (Matthys et al., 2011). 
----Please Insert Figure 6 Here----- 
As outlined above (and in Activity 2), nutrient recommendation setting bodies are compelled to 
use a variety of sources of evidence to derive dietary micronutrient requirements. The 
availability of data from different types of study with various methodological principles and 
designs will influence whether the ‘factorial’ or ‘dose response’ approach is adopted in the 
derivation process (Table 4). The factorial approach principally depends on physiological data 
related to micronutrient losses in balance with absorption. This approach relies on measurements 
of a variety of factors including requirements for growth, pregnancy and lactation and faecal and 
urinary losses that determine requirements to maintain plasma levels or body stores resulting in 
normal tissue and body function and prevention of adverse health effects. Reference values 
derived by this approach also rely on the application of a bioavailability factor (Fairweather-Tait 
and Collings, 2010) to convert the physiological requirement into a dietary intake value. The 
dose response approach is based on the prediction of a physiologically relevant outcome which 
could be the measurement of an accepted micronutrient status biomarker in response to dietary 
intake, or the assessment of clinical disease endpoints in relation to intake or status. Therefore, 
there is a range of study designs that may generate pertinent data including intervention trials on 
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micronutrient exposure up to cohort (nested case control) studies on micronutrient intake or 
status as related to intermediate or late health endpoints. The selection of relevant combinations 
of micronutrients, population groups and health endpoints was discussed previously (see Activity 
3).  
----Please Insert Table 4 Here---- 
Systematic Data Selection 
As illustrated by Figure 6, Identifying and collating relevant data for the derivation of dietary 
recommendations should ideally be undertaken using a clearly defined systematic approach 
which accounts for the micronutrient, population group, and health outcome/end point under 
assessment (Matthys et al., 2011). Following adoption of best practice for intake, status and 
health outcome measures (see Activity 3). EURRECA undertook a series of systematic reviews 
with the primary aim of identifying robust data for all age and life stage population groups, 
useful for the derivation of dietary recommendations for the prioritised micronutrients (vitamin 
B12, iron, zinc, folate, iodine) (Cavelaars et al., 2010). Standardised systematic review protocols 
and search strategies were developed within EURRECA to facilitate collation of data in three 
key areas, namely intake-status-health (association) relationships, micronutrient absorption 
(bioavailability) and factorial estimates. Whilst the rigorous systematic review process ensured 
comprehensive data retrieval, each protocol and search strategy was specifically tailored to 
explicit research questions and issues associated with individual micronutrients. Meta-analyses 
of collated data were conducted to summarise the relevant estimates (Activity 6). 
The standardised systematic review process designed and adopted by the EURRECA network is 
summarised in Figure 7 with further details reported elsewhere (Matthys et al., 2011). Briefly, 
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the process initially involved conducting multi-database searches (Medline, Embase (both on 
OvidSP) and the Cochrane Library CENTRAL database), each including micronutrient specific 
terms and limited to ‘humans’. Potentially relevant studies were identified by searching from 
database inception, and resulting reference lists were screened and sorted on the basis of titles 
and abstracts. References evidently not meeting the purposes of the review, e.g. animal studies, 
were excluded at this stage. In order to ensure consistency between reviewers, and to ensure 
adherence to the inclusion / exclusion criteria, duplicate screening of a minimum of 10% of titles 
and abstracts was conducted independently by two researchers and differences of opinion 
resolved through discussion. Full-texts of potentially relevant articles were collected and 
assessed according to the pre-defined inclusion/exclusion criteria. Abstracts for which the full 
article was unavailable were not included, and articles were considered in a range of languages 
spoken by network partners including English, Dutch, French, German, Hungarian, Italian, 
Norwegian, Polish, Spanish, Greek and Serbian. Again, a minimum of 10% of full-texts were 
independently assessed by two reviewers. Reference lists of retrieved articles and specifically 
reviews on the same topic were also checked for relevant studies not identified in the initial 
search. If appropriate, experts were also contacted to obtain suggestions for additional articles 
that may have provided pertinent data for the review. Data were extracted into a standardised 
database, including bibliographic and methodological information, population characteristics, 
study group details and outcome data. Internal validity indicators specific to the study 
methodology were identified, and relevant information collected during data extraction in order 
to facilitate subsequent assessment of the quality of included studies and the risk of bias.  
Specific details of the search methodologies and data selection used for various EURRECA 
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systematic reviews (dose-response and factorial approach) are described in the following 
sections. 
----Please Insert Figure 7 Here---- 
Building blocks for deriving DRVs 
Factorial approach and bioavailability 
In order to identify data that may be pertinent for deriving recommendations using the factorial 
approach, the EURRECA network undertook a series of systematic searches with associated data 
extraction based on common methodology described above (refer to Systematic data collection). 
The overall aim of this activity was to identify and collate relevant studies and associated data 
relating to micronutrient homeostasis i.e. the balance between losses and maintenance of body 
pools. Collation included identifying and summarising the evidence for the micronutrient 
concentration of breast milk, isotope turnover studies used to assess changes in body pools, and 
measurements of menstrual blood loss. A tailored search strategy was developed for each 
micronutrient which, to enable identification of relevant studies across all age ranges, was not 
limited to specific population groups. However, specific search terms relevant to age and 
physiological stages in relation to micronutrient requirements were included to allow for 
consideration to be given to issues such as growth and development, including the formation of 
new tissues in pregnancy and foetal development. Full details of the methodology can be found 
elsewhere (Hermoso and Vollhardt, 2010). Data were identified for five prioritised 
micronutrients, namely iron, zinc, folate, vitamin B12 and iodine, and databases containing all 
extracted data can be accessed on the EURRECA website (Hermoso, 2010a) along with Endnote 
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libraries of the results of the searches (Claessens et al., 2013; Collings, 2010; Hermoso, 2010b). 
Micronutrient-specific results of the systematic reviews can be found elsewhere in this issue 
(Cashman and Kiely, 2013; Harvey et al., 2013; Hoey et al., 2013; Hurst et al., 2013; Lowe et al., 
2013; Ristic-Medic et al., 2013). The quantitative methodology underlying these reviews is 
explained and illustrated in Activities 5, 6 and 7. 
In many cases the factorial approach cannot be used to accurately derive micronutrient reference 
values without the application of a bioavailability factor to convert the physiological requirement 
into a dietary intake value (Fairweather-Tait and Collings, 2010). Figure 8 shows the basic 
equation that can be employed for the calculation of dietary requirements based on the sum of 
losses and requirements for growth and development adjusted by the appropriate bioavailability 
factor.  Bioavailability is a function of both food (luminal events relating to the composition of 
foods consumed at any one time) and the individual (host) (systemic factors relating to 
physiological need and homeostatic factors) and therefore there is no single bioavailability figure 
that can be assigned to a single food source of a micronutrient. Consequently, host-diet 
interactions play a significant role in determining the amount of dietary micronutrient available 
to enter body pools. In order to assess the state-of-the-art with respect to micronutrient 
bioavailability issues, EURRECA held an expert workshop jointly hosted with the ILSI Europe 
Additions of Nutrients to Food Task Force to discuss the priorities and challenges of setting 
dietary reference values (Fairweather-Tait et al., 2010). In addition to a program of presentations 
focusing on micronutrient-specific aspects of bioavailability, a series of break-out sessions 
challenged the attendees to consider a range of topical bioavailability issues and how they may 
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be addressed. An overarching workshop conclusion highlighted the current lack of micronutrient 
bioavailability data and the associated need for further research. 
----Please Insert Figure 8 Here---- 
Subsequently, in order to attempt to identify robust data that may be used in the calculation of 
bioavailability factors, EURRECA undertook a series of systematic reviews to quantify and 
assess the efficiency of micronutrient absorption from whole diets/meals. The specific aim was 
to analyse and quantify the impact of various dietary enhancers, inhibitors and host-related 
factors (e.g. genotype) on micronutrient absorption. The ultimate goal was to provide an 
evidence base from which bioavailability figures can be derived for setting dietary reference 
values/intakes. Using a similar systematic review methodology to that described above, 
specifically designed search strategies were tailored for each micronutrient followed by 
screening and data extraction. Details on the results of the systematic reviews and meta-analysis 
can be found elsewhere in this issue (Cashman and Kiely, 2013; Harvey et al., 2013; Hoey et al., 
2013; Hurst et al., 2013; Lowe et al., 2013; Ristic-Medic et al., 2013). Further details on the 
methodological approach to summarising and interpreting the data, and integrating the evidence 
can be found in Activities 5 and 6 respectively.  
Dose response approach 
Deriving dietary recommendations using the dose response approach involves assessing the 
dose-response relationships between at least two of the following three components:  dietary 
micronutrient intake (I), micronutrient body status (S) and health (H) outcomes. The three 
relationships of specific relevance are represented in the schematic diagram in Figure 9 and 
include:  
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 the effect of intake on functional or clinical outcomes (I – H) 
 the effect of intake on indicators of exposure or body stores (biomarkers) (I – S) 
 the effect of exposure or body stores (biomarkers) on indicators of functional or clinical 
outcomes (S – H) 
----Please Insert Figure 9 Here--- 
Potential confounders and effect modifiers for the relationships between intake-status, status-
health, and intake-health may include age, sex, country of study, ethnicity, social class/living 
conditions/income, smoking, physical activity, body mass index, total energy intake, intake of 
other macro and micronutrients, acute illness and inflammation, life stage (pregnancy, lactation, 
menopausal stage), exposure and outcome at baseline and genotype. Consequently, careful 
consideration needs to be given to the inclusion / exclusion criteria to ensure that data from each 
included study are appropriate for analysis. 
EURRECA adopted the standardised systematic review approach outlined earlier (Hooper et al., 
2009) (Activity 3) to identify and collate data which were potentially useful for the dose 
response approach. The review for each micronutrient was guided by a protocol that was 
specifically prepared for each micronutrient. The protocol outlined the eligibility criteria for 
studies and data that were suitable for inclusion in the review process. Briefly, these criteria 
included:  
 Population groups: infants, children and adolescents, adults, pregnant and lactating women 
and elderly. 
 Only intervention and observational studies (except for intake-status studies where cross-
sectional data were also considered).  
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 Dietary intake data (if assessed using the standards approved in the Best Practice Guidelines 
for intake (Activity 3)). 
 Status data (if the biomarkers of status used for the assessment were identified in the Best 
Practice Guidelines for status (Activity 3). 
The study selection was a stepwise process. Following the search, the initial step was the 
screening and sorting on basis of title and abstract (minimum 10% duplicate screening by 
independent reviewer), followed by sorting by relationship (intake-status, status-health, intake-
health and intake-status-health) and population groups (adults & elderly and infants, children, 
adolescent, pregnant & lactating women). Following full text assessment of all potentially 
relevant papers (minimum 10% duplicate review by independent assessor) key data were 
extracted and entered into an Access (Microsoft) database (Claessens et al., 2013).Variables of 
interest included intake, status and health outcomes and measures of the relationship; other 
relevant extracted data included information on study design, confounders, population size, study 
duration and methods of intake and status measurement. In addition, a set of indicators of 
internal validity specific to the type of study e.g. RCT were collected in order to assess the 
quality of the study and the risk of bias. This included method of sequence generation and 
allocation, blinding, potential funding bias, number of participants at start, dropouts, dose check, 
outcome comparability and reproducibility, and similarity of most and least exposed groups at 
baseline. Based on these indicators, two reviewers decided on the overall risk of bias. 
Disagreements were resolved by discussion. The criteria for judging these indicators were 
adapted from the Cochrane Handbook (Higgins and Green, 2008). Databases and search libraries 
for each of the EURRECA priority micronutrients can be accessed on the EURRECA website 
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(Berti et al., 2010; Claessens et al., 2013). Details on the results of the systematic reviews and 
meta-analysis on specific micronutrients can be found elsewhere in this issue (Cashman and 
Kiely, 2013; Harvey et al., 2013; Hoey et al., 2013; Hurst et al., 2013; Lowe et al., 2013; Ristic-
Medic et al., 2013). Further details on the methodological approach to summarising and 
interpreting the data, and integrating the evidence can be found in Activities 5 and 6 respectively.    
Inter-individual variability 
The variation in requirements between individuals within different population groups is 
generally assumed to be normally distributed, but definitive data are limited to only a few 
nutrients. Where data are available, the Population Reference Intake (PRI) is set at the average 
requirement (AR) plus two standard deviations, thus meeting the requirements of 97.5% of the 
population. In cases where requirements are not normally distributed, appropriate transformation 
of the data is undertaken to achieve normality. In the majority of cases where data on the inter-
individual variation in requirements are unavailable, a coefficient of variation (CV) between 10-
20% is used assuming a normal distribution.  The selection of CV is made on a case-by-case 
basis and is set at 1.2, 1.3 or 1.4 times the average requirement for CVs of 10, 15 and 20% 
respectively. 
Variability is due in part to influences of gene polymorphisms on nutrient function within the 
body. Therefore, the EURRECA network identified data pertinent to understanding or explaining 
inter-individual variability in micronutrient requirements for different population groups.  
Regarding biological variation in requirements, EURRECA explored effects of single nucleotide 
polymorphisms on micronutrient metabolism, metabolomics data from a multiple micronutrient 
intervention, and examined biological networks to better understand the interplay between 
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micronutrients and health at the individual level. To this end, extensive description of the 
subjects being studied and foods or diets consumed is central to characterise the so-called 
nutritional phenotype. For this purpose a “Nutritional Phenotype database” (dbNP) was 
developed in collaboration with Nutrigenomics Organisation (NuGO) and the Netherlands 
Metabolomics Centre (www.dbnp.org) (van Ommen et al., 2010). The primary aim of this 
activity was to generate a module for this database containing relevant information on the 
relation between functional gene polymorphisms on micronutrient metabolism and intake.  
Specifically, this involved identifying data assessing the impact of functional polymorphisms 
(e.g. single nucleotide polymorphisms, or SNPs) on micronutrient status biomarkers and 
associated health outcomes. Five micronutrients were evaluated namely iron, zinc, vitamin B12, 
selenium and folate.  
Inclusion in the polymorphism database required studies to report a statistically significant 
association between a genotype of relevance to the micronutrient and a EURRECA status 
biomarker (Activity 3). Searches were conducted using the CENTRAL Cochrane Library, 
Medline and Embase (both on OvidSP) databases and were based on specific micronutrient, 
status biomarker and polymorphism terms and limited to humans. Potentially relevant articles 
were screened and identified in accordance with the process described above. Data from relevant 
papers were extracted into a tailored database (Claessens et al., 2013) designed to ensure capture 
of all relevant data.  Statistical data on significant relationships pertaining to relevant genotype-
status associations were recorded along with specific information on the polymorphisms and 
demographic details of the population group under evaluation. The resultant database is available 
as a web resource at http://web-php06.tno.nl/eurreca/index.php and further details on key 
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polymorphisms associated with micronutrient status are included in each of the micronutrient 
summary papers for iron (Harvey et al., 2013), zinc (Lowe et al., 2013), selenium (Hurst et al., 
2013) and folate (Hoey et al., 2013). To date, due to the lack of relevant data, no information 
related to SNPs have been used in the derivation of DRVs. The collation of polymorphism data 
into a single database by the EURRECA network is an initial step towards recognizing future 
developments and the likelihood of such data being incorporated into the derivation of 
micronutrient requirements. 
Deriving dietary reference values: Appraisal of the evidence (Activity 5) 
Once the relevant papers are identified and the data extracted, it is critical to transparently 
summarize and interpret the available evidence. Systematic literature searches provide the basis 
for narrative reviews that summarise the studies one by one and qualitatively compare and 
interpret their results qualitatively. If the health outcomes and exposures are sufficiently 
comparable, systematic literature searches also provide a basis for quantitative reviews or meta-
analyses to go beyond this qualitative review process by systematic extraction and presentation 
of the quantitative pieces of information, to analyse their variation, and – if possible – pool them 
to obtain a summary estimate. 
Because of unavoidable shortcomings in study design, recruitment, measurement of dietary 
exposure and health outcomes, etc, the scientific data are subject to random and systematic error 
and scientific expert opinion is required to decide on in- or excluding studies for further 
quantitative summary. Therefore, the available studies need to be evaluated according to the 
quality of their information. To improve transparency of this expert-based qualitative step, the 
quality indicators of the reviewed papers should be clearly and consistently described.  
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Study design: observational studies & RCTs 
Historically a framework based on ‘hierarchy of evidence’ has been applied for basing to judge 
the strength of evidence according to study design. This is because different study designs have 
different strengths and weaknesses and, thus, different value in informing decisions. Typically, 
more weight is given to good quality randomised controlled trials (RCTs) and less weight to 
observational (non-intervention) studies. The rationale is that observational studies are 
potentially subject to bias and additionally cross-sectional and case control studies may be 
subject to reverse causality. In spite of this, observational data can also provide useful 
information if studies meet rigorous quality criteria as set by different authorities (SACN, IOM, 
EFSA, NORDICS). To examine intake-status-health (I-S-H) associations, systematic reviews 
were conducted within the framework of EURRECA. RCTs and observational (cohort and cross-
sectional) studies, were considered, while case control studies were excluded (nested case control 
studies were included). Cross-sectional studies were considered only to evaluate associations that 
describe steady state relations, e.g., between usual nutrient intake and concentration markers, or 
between socio-economic indicators, micronutrient intake and concentration markers. Depending 
on the sources of evidence, there are different ways to assess data quality through the application 
of criteria to assess internal validity (see below). In the framework of the EURRECA systematic 
reviews, indicators of internal validity were collected during data extraction in order to assess the 
risk of bias. The indicators are based on Cochrane guidelines and others (Higgins and Green, 
2008).  
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Observational studies  
For cohort studies, the following indicators of internal validity were considered: similarity of 
most & least exposed groups at baseline (in terms of stated confounders), adequate adjustment of 
potential confounders in the analysis, adequate exposure assessment, completion of dropouts and 
outcome data, potential funding bias, and other threats to validity. 
For cross sectional studies, the following indicators of internal validity were considered: 
similarity of most & least exposed groups at baseline (in terms of stated confounders), adequate 
adjustment of potential confounders in the analysis, adequate exposure assessment, and potential 
funding bias and other threats to validity (see supplementary document 3 for more details). 
Randomised Controlled Trials 
For studies employing a RCT design, the following indicators of internal validity were 
considered: method of sequence generation and allocation concealment, blinding, dropouts and 
dropout reasons, potential funding bias, number of participants at start, dose check (amount of 
micronutrient provided), dietary intake data reported, outcome comparability and reproducibility, 
and baseline comparability for determinants of the outcome in the intervention and control 
groups. Specific criteria are defined in order to assess if the judgement for each item is yes, no, 
or unclear. For instance, the allocation sequence of an RCT will be adequately generated if the 
investigators describe a random component in the sequence generation process such as: referring 
to a random number table, using a computer random number generator, coin tossing, shuffling 
cards or envelopes, throwing dice, drawing of lots, or minimisation (see supplementary 
document 3 for more details). 
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For all study designs, based on their respective indicators, two independent reviewers decided on 
the overall risk of bias (low, moderate, high). For example, in the case of RCTs, low risk of bias 
was established if internal validity criteria 1-6 were met. Disagreements were resolved by 
discussion. The criteria for judging these indicators were adapted from the Cochrane Handbook 
(Higgins and Green, 2008). Further tests can be applied to assess the methodological quality of 
interventional studies. For instance, the Jadad score is a tool where studies are scored according 
to the presence of three key methodological features of randomisation, blinding and 
accountability of all patients, including withdrawals. The methodological quality of the study is 
then classified into low, medium, or high quality (Houthuizen et al., 2012). 
Evaluation of heterogeneity 
The overall grading of the evidence is based on the totality of evidence and contains elements of 
judgement in addition to the assessment of the internal validity as such. The first step is to 
evaluate whether heterogeneity of results can be attributed to differences in internal validity. 
Therefore, in the meta-analysis for each of the study types (RCT, prospective and cross 
sectional) sensitivity analyses were conducted by stratification for ‘low risk’ and ‘> low risk’: the 
overall evidence was graded as low risk if there were ‘low risk’ studies present and if the results 
were stable upon exclusion of the studies with ‘> low risk of bias’. In addition, study results were 
compared between the design types using the RCT (if available) as the reference design; the 
highest graded study types and study quality was used for arriving at conclusions. 
Secondly, once the usable evidence has been identified, in-depth knowledge about specific 
characteristics of the study populations (e.g. physiology, clinical aspects) is necessary for 
adequate judgement of the generalizability of results. This judgement will permit deriving 
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appropriate conclusions which will have important implications for practice and further research. 
Therefore, based on the number of studies and number of participants, the numerical result and 
its 95% CI, the heterogeneity of the results is evaluated (which includes statistical tests of 
heterogeneity). In this process, also characteristics of the micronutrient exposure (dietary or 
pharmacological doses, chemical species, food matrix) and population characteristics are 
accounted for (serious nutritional deficiency, or generally adequately fed; in children, adults and 
the elderly, men and women, etc). Thus, the judgement is therefore based on the consistency, 
strength and quality of the studies, and takes into account all the available evidence obtained 
with the various methods, including the knowledge on the mechanism linking nutrient intake and 
the occurrence of chronic disease (EFSA, 2010; Sheffer and Lewis Taylor, 2008). 
In EURRECA the heterogeneity in status or health outcomes was mainly related to dose, and to 
some extent to life cycle and sex, but not clearly to other covariates. As long as individual patient 
data are not available to better account for covariates, this implies that the heterogeneity is a real 
phenomenon that describes the extent to which different populations behave differently. Because 
the results of DRVs are being applied to different populations in different contexts this variation 
has to be part of the pooled estimate and has been incorporated in the derivation of DRVs.  
Overall quality of the evidence  
The assessment of the quality of the data, the inclusion of elements of judgment and the 
remaining heterogeneity will result in quantitative estimates that do need a number of qualifiers 
to inform both scientists and decision-makers about the appropriate use of these data for deriving 
DRVs. 
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An example of the judgemental issues can be seen in the EURRECA analysis for Vitamin B12. 
Estimates on micronutrient losses and of bioavailability were derived from different populations 
but were integrated to arrive at an estimate of the AR. Regarding the dose response approach, 
there was a sufficient number of adequate RCTs and observational studies to evaluate the intake-
status (I-S) association in order to derive ARs in adults and elderly, but extrapolation to younger 
age groups would be required. On the other hand, there was insufficient sound epidemiological 
evidence for deriving ARs based on the I-H or S-H relationship when considering cognitive 
function as the health endpoint.  
Scientific decisions concerning the micronutrient needs of populations should be informed by the 
best available research evidence. Decision-makers are encouraged to make use of the latest 
research and information, and to ensure that decisions are demonstrably rooted in this 
knowledge. However, this can be difficult given the large amounts of information generated by 
individual studies. Carrying out and clearly documenting the meticulous task of summarising 
data and their well-informed interpretation will lead to a more transparent and reliable decision 
making process.  
Deriving dietary reference values: Integrating the evidence (Activity 6) 
Deriving dietary reference values originated in dates from the era of deficiencies. Their ability to 
meet the present health challenges must be evaluated and new approaches need to be developed 
to are required that can incorporate epidemiological evidence on chronic diseases, are be in line 
with concepts in risk assessment, build on aetiological models of disease causation, and are be 
consistent with current approaches to evaluate and recommend on population nutrient intake 
(Sheffer and Lewis Taylor, 2008).  As explained in Activity 1, there is a gradual shift from 
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setting dietary reference values (DRVs) based on preventing deficiencies and on amounts needed 
to maintain body stores (Activity 4) to optimise health, prevent chronic disease, and avoid 
consuming too much of a nutrient. The interest in using risk reduction of chronic disease as the 
basis for establishing micronutrient recommendations requires insight in the causal relationship 
between micronutrients and the disease or health outcome (Activity 4). This places greater 
emphasis on which nutritional intermediates or health outcomes are being considered and where 
the resulting distribution of requirements is positioned for the apparently healthy population 
rather than using a distribution which suffices to repair a single micronutrient deficiency until 
normal function is achieved (see Figure 6). Additionally, the relationship between the intake of a 
nutrient (I) and the risk of disease (D) based on scientific evidence needs to be quantified. 
Consequently, a dose-response relationship between intake (I) and status/functional markers (S) 
must be determined. The integration of the evidence has to accommodate systematic variations 
between studies originating from (1) differences in study quality (assessed by internal validity), 
(2) study population (age, gender, body composition and energy needs), (3) micronutrient dose 
(level, range, duration, mode of administration), and (4) other population characteristics (growth, 
pregnancy, lactation, etc.).  
Quantification of the evidence 
The principles of meta-analysis to quantitatively summarize research data, have been sufficiently 
described (refs). In this Activity specific issues relevant to the meta-analyses conducted in 
EURRECA are briefly outlined. As described in Activity 4, standardised systematic review 
protocols and search strategies were developed within EURRECA. Following appraisal of the 
evidence, study results were visualised by forest plots, (see Supplementary document 4). Of 
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course, this approach requires assumptions on the shape of the dose-response relationship. To 
quantify the strength of the dose response relationship, the rigorous but flexible transformation to 
a double loge-scale was chosen. This transformation is suitable to describe dose response as a 
non-linear but monotonic concave function of dose, i.e. the same additional dose is less effective 
at higher levels of intake, which is considered a common phenomenon shape in biology (see 
Figure 10). This transformation can be applied to both RCT data and observational data and also 
allows one to compare and integrate RCT and observational studies on intake and biomarkers of 
status (Bar et al., 1991). Clearly, the use of this double loge scale is specific for continuous 
responses and not applicable for dichotomous outcomes (although risk is usually also modelled 
on the loge scale). In principle, when the health criterion for the specified health outcome or 
status has been defined, an appropriate average requirement (AR) can be derived. In addition to 
measures of dose-response, it is also possible to meta-analyse data on the correlation between the 
intake and response. This can be used to arrive at a stochastic model to derive ARs and PRI. The 
regression slopes of this model are based on results from intervention studies using high doses of 
micronutrients, whereas the intercept for the regression lines is determined by the means of the 
usual dietary intake and the mean value of the concentration marker. As the range in intake in 
intervention studies is large as compared to usual dietary intake, it is at present assumed that the 
well-known errors in the latter assessing the mean baseline population intake are  not likely to 
cause large systematic errors in our approach. For the transformation of extracted estimates, the 
derivation of study-specific regression slopes and the pooling of these slopes, we refer to 
Supplementary document 4.  
----Please Insert Figure 10 Here---- 
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Expert consultation  
Expert knowledge and critical evaluation will always be needed for the appraisal of the collected 
data, interpretation of the results and potential refinement of the analysis. Transparency and 
alignment of (the process of setting) micronutrient recommendations is necessary to improve the 
objectivity and transparency of values that are derived by national, regional and international 
groups; provide a common basis or background for groups of experts to consider throughout 
processes that lead to micronutrient recommendations; supply a common basis for objectives and 
national policies such as fortification programmes and for addressing regulatory and trade issues 
(King and Garza, 2007). Following this procedure the expert consultation is pivotal at several 
moments in order to keep track of content-related issues, nevertheless the expert’s opinion 
should aim for transparency (EFSA, 2009; European Commission, 2000, 2001b). As introduced 
in Activity 1, experts should be consulted to check the prioritisation process. Scientists who 
already are familiar with the topics (either micronutrients or health outcomes) should ideally 
perform the systematic reviews. For the integration of the available data, the experts should be 
re-consulted in order to address remaining issues to be solved, check for completion and for 
correct representation of the data.  
Factorial & bioavailability approach 
Activities 4 and 5 described the data collection of factorial and bioavailability studies. The 
resulting pooled estimates of needs (numerator) and bioavailability (denominator) are used to 
derive the AR which represents the intake at which an individual has a 50% chance of meeting 
his or her requirements. In case the requirements apply to specific population groups, such as 
infants, children, pregnant women or lactating mothers, the requirements depend on basic 
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physiological needs plus an additional amount to account for growth or additional needs 
(lactation), which requires a combination of factorial and other methods to derive ARs. 
To allow for between-subject variation in requirements, a distribution of individual nutrient 
levels is postulated, with its SD usually set at a CV of 10-20% of the AR. Moreover, deriving an 
AR is associated with many uncertainties. For instance, most factorial estimates and 
bioavailability studies included relatively small selected population groups, did not address all 
factors in the factorial model, did not always address whole meals or food patterns (essential to 
calculate a universal bioavailability factor), etcetera. Therefore the estimated AR also contains 
scientific uncertainty. If there is much uncertainty in the estimation of the AR and little is known 
on the distribution of individual requirements, then usually the higher CV is selected.  In 
principle, high quality studies or variables that can explain biological variability in nutrient needs 
could lead to the choice of a smaller CV for subgroup-specific ARs. 
When using the factorial approach to derive reference values, information on dose response 
studies and other health outcomes must be considered as well. In principle, the factorial estimates 
and dose response estimates on intake-status-health relationships are based on methodologically 
independent data and for setting the reference values, the combined quantitative information of 
the factorial estimates and dose response data should be both considered (see Figure 2 and 
Activity 1).  
Dose-response model  
The dose-response approach ideally combines I – S, I – H, and S – H data. Within the scope of 
the EURRECA network, a bivariate stochastic model was initially used to describe the relation 
between micronutrient intake and status (I – S) by incorporating the variability between 
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individuals for both intake and status measures (Bar et al., 1991). Although most nutritionists are 
not familiar with this type of bivariate models, this approach is commonly used in food safety. 
Although Carriquiry (Carriquiry, 1999) has used a stochastic model to underpin the AR-cutpoint 
method for evaluation of population intakes, our stochastic model is different as it uses 
biomarkers and intake data to derive the AR. Apart from a meta-analysis of associations 
(Activity 5), the model additionally requires information on the correlation between the two 
variables (the stochastic component) as well as average intake and average status (e.g. from 
monitoring data) to allow for the predictive component of the model. Dullemeijer et al (1991) 
based the associations of their stochastic model on the RCTs and the intercepts on observational 
studies identified for vitamin B12 intake and status: The joint distribution of loge intake and loge 
plasma or serum vitamin B12 concentrations is assumed to be bivariate normal with means (µX, 
μY), standard deviations (σX, σY) and correlation ρ, implying a linear dose-response relation on 
these scales. 
Using the assumption that the AR represents an intake which is sufficient for 50% of the 
population (Activity 1), the PRI may be derived under the assumption of parallel individual lines 
as the intake at which the probability of reaching vitamin B12 status is equal or less than the cut-
off of 2.5%. Finally, for the derivation of reference values the bivariate marginal distribution I-S 
is of interest once thresholds on the health or status variable are set; the trivariate model could 
simultaneously account for the I-H and S-H associations as well. Scenarios regarding desirable 
changes in nutrient intake are considered as shifts of the bi/trivariate distribution along the 
regression line for predicting the status or health outcome. The model can be used to derive 
intake levels which would be required to attain desirable values of I or S for specified 
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proportions of the population (resembling though not analogous to the definition of AR and PRI) 
(Figure 11). It should be noted that the bivariate I-S model is based on physiological health 
criteria, similar to most applications of the factorial approach.  
----Please Insert Figure 11 Here---- 
A major advantage of the stochastic method is that it largely extends the evidence base for 
deriving DRVs because it allows the use of widely available dose response data on I-S and I-H 
associations from different types of studies (RCT’s and observational). However, the 
practicability of this stochastic method for deriving the AR and recommended intake depends on 
the justification of the assumptions made. Further work needs to be done to evaluate the 
sensitivity to these assumptions and to allow for these limitations.  
So far, EURRECA explored a bivariate stochastic model, but it can be extended to a trivariate 
model, which also includes health outcomes in addition to intake and status. The trivariate 
intake-status-health (I-S-H) model could incorporate all published information from randomised 
controlled trials (RCT) and observational studies on the I-S, I-H and S-H dose-response 
association, as the basis for deriving micronutrient reference values. In short, the trivariate model 
combines the evidence of the three I-S, S-H and I-H dose-response associations in separate meta-
analyses, the results of which are combined using the assumption of conditional independence, 
i.e. the effect of I on H is fully mediated by S. This integrated evidence is then combined with 
the results of the meta-analyses of the data on the marginal distribution of I, S and H to obtain 
the final trivariate stochastic model. Future extension of the model could incorporate covariates 
and/or individual patient data (rather than meta-analysed data). 
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Scaling of ARs to other population groups 
When no original research data are available for certain population groups – most often this 
concerns infants and children – other methods need to be applied to define and align reference 
values or Ars. The derivation of DRVs for infants and children in current dietary reference 
standards is often based on methods of extrapolation or interpolation (or in other words scaling) 
from adult data or breast milk, owing to the paucity of relevant research data available, but these 
are not consistent across reports (Atkinson and Koletzko, 2007).   
Currently, the different methods used for the derivation of DRVs for infants and children in 
Europe and worldwide have led to considerable differences and inconsistencies in DRVs and age 
groups between countries for the same age group of infants or children. (Atkinson and Koletzko, 
2007) (Prentice et al., 2004). This diversity of values may be attributed to one or more of the 
following points: a) no universally accepted growth or (considerable differences in) reference 
data, b) source documents often do not provide detailed information on the derivation of the 
reference values, c) lack of nutrient-specific growth factors that take into account specific 
metabolic properties and the turnover of each micronutrient, d) varying content of nutrients in 
breast-milk among different studies, e) use of different extrapolation methods to obtain DRVs 
and recommendations in each country, f) inconsistent application of scaling methods within one 
age group.  
There are several methods for extrapolation which are based on different assumptions. Within 
EURRECA we selected two methods which are used most often and which are considered 
adequate to estimate requirements (see Figure 12).  
----Please Insert Figure 12 Here---- 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 65
Biological modelling for multiple micronutrients 
For personalised multi-micronutrient recommendations information at biological process level 
should be integrated and visualised. To this end, the ‘health space’ model was developed (Figure 
13). This model is a statistical visualisation method, which addresses the effects of treatment in 
individual subjects. The visualization is based on predefined biological processes as determined 
by systems-biological datasets (metabolomics, proteomics and transcriptomics). This allows one 
to evaluate biological effects depending on shifts of either groups or subjects in the space 
predefined by the axes, which illustrate specific biological processes. We built a conceptual 
multivariate model for each axis to represent several biological processes. In this space each 
subject has his or her own score on each axis/process, indicating to which extent the treatment 
affects the related process (Bouwman et al., 2012). For instance the oxidation status can be 
represented by an axis which is quantified by a combination of markers (Bouwman et al., 2012; 
van Ommen et al., 2008). Assessment of the individual’s health status by measuring these 
markers combined with the collated evidence for micronutrient (e.g. vitamin C and E) effects on 
these markers (Activity 3) allows for individualised micronutrient recommendations based on the 
nutritional health space.  Applying the health space method on data of a human intervention with 
an anti-inflammatory dietary mix, has shown that the model allows visualization of an 
individual’s health status based on the assembly of omics data in biologically relevant processes 
multiple results and facilitates the interpretation (application of the health space is extensively 
described in (Bouwman et al., 2012)). The health space in the published example was built on 
treated (with a dietary anti-inflammatory mix) and untreated subjects. The model in his example 
presents treatment group effects, subgroups and individual responses, since all subjects are 
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represented individually in the health space visualisation. In this example, it was assumed that 
treated subjects were more healthy than untreated. Unfortunately As health does not have an 
absolute definition, which makes it is hard to define the precise location of the origin , which 
reflects by definition the most healthy status in the health space visualisationof the space. 
However, the model may help to define a healthy area and may show that the health area may be 
different for certain subgroups. With the underlying models linking micronutrients to specific 
processes, different dietary recommendations may be derived for these different subgroups. This 
concept is currently applied and further extended at IABC (www.iabc.ch). Regarding 
micronutrient function, within EURRECA, the relationship between micronutrient intake and/or 
status and a range of biomarkers (e.g. metabolomics), representing inflammatory, oxidative 
stress and metabolic stress processes, was reviewed (www.micronutrientgenomics.org  or 
http://wiki.nugo.org/index.php/Category:Micronutrients). The selected biomarkers are 
metabolites that are known to respond to dietary interventions and are associated with (or are 
predictive of) certain chronic metabolic diseases. For selenium, folate and vitamin B12 
biological networks have been developed on the basis of metabolic connections between 
micronutrient markers of exposure to food components, markers of target function and biological 
response, micronutrient-related status metabolites and micronutrient-related disease parameters 
(see http://www.wikipathways.org/index.php). This concept is an interesting option to be further 
explored for mechanistic underpinning and incorporation of the individual’s genetic information 
(van Ommen et al., 2010).  The health space model could eventually provide a mechanistic 
underpinning for other models such as the Intake-Status bivariate model and the I-S-H trivariate 
model. 
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----Please Insert Figure 13 Here---- 
Monitoring and evaluating: Nutrient intake & status of population groups (Activity 7) 
Dietary Reference Values are the main instrument in diet planning and nutritional assessment.  In 
addition to evaluation and monitoring of nutritional situation, they also supply the information 
necessary for the development of food labels, nutrition programs and for regulations related to 
fortification.   
In Europe, data collected by surveillance are used to evaluate population nutritional health and 
give early warning information on malnutrition and nutrition health related problems. That 
implies that surveillances are considered as a first “screening test” to identify potential 
nutritional problems.  
Within EURRECA, nutrient intake values were used for evaluating the dietary adequacy of 
population groups and for identification of those that are at risk of low intake. Upper levels of 
micronutrient intake that could induce a risk of excessive intake both from the diet and 
supplements were not addressed by EURRECA.  
Assessing dietary intake and nutritional status 
Assessment of dietary intake and nutritional status is used to  estimate the proportion of the 
population that is at risk of inadequacy, that is, whose nutrient intake and status levels are below 
the reference cut off values (Jensen et al., 1991). Within the EURRECA Network, the dietary 
assessment instruments and population surveillance data and the methods to evaluate inadequacy 
of micronutrient intake in Europe were reviewed (Activity 3).Two methods are preferable to 
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evaluate adequacy of intake at the population level: the probability approach and the cut-point 
method (Carriquiry, 1999), with the latter used most widely (Tabacchi et al., 2009).  
For application of either method, a reliable estimate of population usual intake is needed.  Usual 
intake reflects only the variation in usual intake among members of the population and should 
exclude day to day variability in daily intakes (Jensen et al., 1991).  It implies shrinking the 
distribution of observed intake to accommodate for random measurement errors, i.e. assuming no 
systematic error. In addition, estimated usual intakes of individuals should be independent of 
each individual’s requirement. To use the probability approach the joint distribution of usual 
daily intakes and of requirements should be known. Figure 14 presents an example of how risk 
of inadequate intake can be estimated if the distribution of requirement or a given micronutrient 
is known.  
-----Please Insert Figure 14 Here---- 
However, although data on usual nutrient intakes are available, information on requirement 
distribution are seldom explicitly known and thus for many micronutrients a rough estimate of 
the AR and its SD is often used  for the life stage groups considered.  
The cut point method does not require such extensive data on the distribution of requirements, 
but some other assumptions must be fulfilled: i) when intakes and requirements must be 
independent or have low correlation, ii) the requirement distribution must be symmetric (e.g. the 
iron requirements distribution in menstruating women is known to be highly skewed due to iron 
losses) and iii) variability in intakes among individuals in the group must be large compared to 
the variability in requirements of the individuals (Institute of Medicine, 2000). The cut point 
method estimates the prevalence of inadequacy as the proportion of individuals whose usual 
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intake is below the AR (AR: amount of nutrient that covers 50% of the population’s 
requirements). Figure 15 shows an example of the application of the AR- cut point method for 
joint intake and requirement data.  
----Please Insert Figure 15 Here---- 
To identify vulnerable groups with inadequate micronutrient intake and/or status, a search was 
conducted in open access and grey literature sources. The aim was to collect the best quality data 
that report on micronutrient intake and/or status, and that fulfil a priori quality criteria for study 
characteristics (Activity 3). Studies that were included in the analysis had focused on the 
EURRECA prioritized micronutrients and had used the EURRECA recommended best practice 
dietary intake assessment methods and biomarkers of nutritional status (Activities 1 & 3). Data 
were collected for all life- stage groups including low income and immigrants.  Despite 
limitations on the intake data gathered this way, primarily lack of data for some age groups and 
non-harmonised study methodologies, the cut point method was applied to evaluate the 
proportion of the population at risk of nutritional deficiency. There were used Average 
Requirements derived for the Nordic countries (Nordic Council of Ministers, 2004) as these are 
the most recent references values set for a series of European countries. If ARs for 
micronutrients in Nordic countries were not reported (calcium and vitamin D in adults, all 
micronutrients in children), ARs published for the USA/Canada by the Institute of Medicine of 
the National Academies, Food and Nutrition Board, were used (Institute of Medicine, 1998).  
Data on intake of vitamin C, vitamin D, vitamin B 12, folic acid, calcium, zinc and iron (males 
only) from seven European countries were used for assessment of inadequacy by applying the 
cut point method. Figure 16 shows the proportion of micronutrients, for which there are 
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inadequate intakes above 20%. Among males, the highest ratios of inadequate intakes were 
found in Finland and Sweden: out of seven micronutrients analysed, there was observed 
inadequate intake of three and four micronutrients, respectively. Among females, for which 
inadequacy was estimated for six micronutrients, the highest ratios of inadequate intakes were 
found in Ireland and the UK: six and five micronutrients, respectively.  
----Please Insert Figure 16 Here---- 
For the populations where the study data did not meet the best practice criteria for intake 
methods (Activity 3) the AR cut-point method could not be  applied: for example, methodologies 
to assess micronutrient intake differed widely between nutritional surveys from Central and 
Eastern Europe. More specifically, for estimating micronutrient intake, the remaining random 
error was large for FFQs, whereas for the 24hR-based surveys, it was dependent on the number 
of replicates and the use of shrinkage methods. Therefore, the width of the distribution of intakes 
lacked comparability between the surveys, which prohibited estimation of the prevalence of 
micronutrient inadequacy. However, their ability to (roughly) estimate mean population intake 
was considered sufficient, so reported mean intake levels were compared with the ARs proposed 
by Nordic Nutrient Recommendations (Nordic Council of Ministers, 2004).  Figure 17 shows 
mean calcium intake in milligrams per day (standard deviation) by country, for males (M) and 
females (F) (Novakovic et al., 2013). For those countries where the mean intake was below the 
AR, there is clearly a risk of inadequacy: in CEE, four out of eight countries had a mean intake 
of calcium below the AR among males, and in three countries among females.   
----Insert Figure 17 here----- 
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With respect to evaluation of biomarkers for adequate micronutrient status, the EURRECA Best 
Practice Guidelines were followed (Activity 3). Cut-off values to indicate a risk of inadequacy in 
micronutrient status were defined on the basis of a literature review and were mainly based on 
values proposed by the World Health Organisation and other authorities. Figure 18 shows an 
example of evaluation of iodine status for children and adolescents in Europe: data from Central 
and Eastern Europe indicate to mild iodine deficiency in some countries (Novakovic et al., 
2013).  
----Insert Figure 18 here---- 
The former approaches to evaluate micronutrient inadequacy have intrinsic limitations. To 
enable comparison of the data that stem from the studies with different dietary methodologies. 
The best practice guidelines required that a single 24hr recall or food records, or replicates for at 
least 3 days, if less than 3 days then adjusted for intra-individual variability, or a validated FFQ 
(Activity 3).For micronutrients found in a limited number of foods, using a short term reference 
period will probably miss information on frequency of intake, whereas an FFQ will overestimate 
the intake of certain food groups such as vegetables (Roman Vinas et al., 2011). These reporting 
errors will affect the validity of the prevalence of nutrient intake inadequacy when applying the 
cut point method.  
For the cross country comparison, even though when countries had applied the same 
methodology for estimation of prevalence of inadequacy such as the cut point method, diversity 
in country specific dietary reference values (e.g. AR) can induce a substantial variation in 
estimating the prevalence of inadequacy.  
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Assessing health status reflecting the nutritional status 
Biomarkers for measuring nutrient status identified by EURRECA are to be used for 
epidemiological analysis and can be obtained from blood or urine.  The list of biomarkers used in 
EURRECA for evaluation of inadequacy in status was a result of the literature review of the key 
publications issued by the World Health Organisation (WHO), the Institute of Medicine and 
other authorities, as well as consulting micronutrient experts. More details on other biomarkers 
and the methodology of Best Practice Guidelines (BPG) (Activity 3). 
Reported levels of priority micronutrients (folate, vitamin B12, zinc, iron and iodine) were 
compared to reference values proposed in Activity 3, the latter being based on key references 
mostly published by the World Health Organization in cooperation with other institutions 
(Activity 3).  The levels below the cut off or below the optimal range point to a risk for 
inadequacy, i.e. depending on the marker used, there were indicated that the dietary intake was 
insufficient over the medium or long term. 
These biomarkers can be used either in analysis of epidemiological data or to be applied in field 
work. Some of them are used those to indicate a health risk. For example, the most common 
cause of anaemia is iron deficiency and the blood levels of haemoglobin concentrations can be 
used to detect long term inadequate intake of iron. From the public health perspective if the 
prevalence of anaemia at 4.9% or less, it is categorised as acceptable proportion of inadequacy 
(Gorstein et al., 2007). Another example is iodine: median level of urinary iodine concentration 
reflects iodine nutrition and it is used to detect mild to severe iodine deficiency.  
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Identifying vulnerable groups  
In Activity 1, population (sub) groups which are vulnerable because of higher requirements, 
accounted for in deriving DRVs have been addressed. Here, we focus on vulnerability because of 
high risk of low intake rather than increased physiological needs. Low income and immigrant 
groups tend to have less optimal nutritional status because of a lower intake (Church et al., 2006; 
Darmon and Drewnowski, 2008; James et al., 1997). Identification of such groups may be 
relevant to the formulation of micronutrient policies. Therefore, EURRECA collected European- 
wide data on micronutrient intake and status in order to identify such vulnerable population 
groups for a selected set of micronutrients. To do so, an initial step was to have clear definitions, 
i.e. search terms to be used for identification and analysis of the studies from scientific electronic 
databases.   
To define low income groups, key documents were screened on poverty, socio-economic 
status/position and diet: systematic reviews available in open access database (PubMed), The 
WHO and collaborating bodies’ publications (DETERMINE Project Working document No1, 
www.health-inequalities.eu;  http://www.who.int/en),  EC/Eurostat statistical information 
(www.ec.europa.eu) and data from grey literature (Brandolini, 2009). Based on these data, search 
terms for low income groups were defined: low income, indigenous population, social class, 
poverty and socioeconomic factors.  
Search terms for immigrants involved commonly used descriptors as proposed in PubMed 
database: emigration and immigration, migration, foreigner, resettlement. With respect to 
definition of host country, European Union was limited to those comprising the former EU-15 
till 1st May 2004. To collect the data on intake in low income and/or immigrants, a 
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comprehensive review was conducted that included a structured Medline search, related 
references screening and key expert consultations. Study inclusion criterion followed general 
EURRECA guideline on dietary intake and study characteristics (Activities 1 & 3). 
Immigrant and low income/low SES groups  
Evidence suggests that immigrant populations constitute a vulnerable group for inadequate 
nutrient intake, of which the most marginalised and isolated groups, such as the Roma/Gypsy 
populations, present higher risk (Ngo et al.). They often try to maintain their traditional food 
pattern and the food chains in their new societies do often do not provide the opportunity to do 
so. On top of that, the language and financial means may inhibit socialisation putting them on the 
lower socioeconomic strata of the recipient country. Poor socioeconomic status and life style 
factors, including diet might contribute to their nutritional vulnerability.  
People from low-income households typically have less nutritionally adequate diets, especially 
those who live for long periods of time on limited incomes. In addition, among other factors, 
lower literacy, numerical and language skills, physical disabilities and mental health problems 
are more common in low-income groups, as well as low motivation, and as such, constitute 
obstacles when identifying and assessing this population’s food and nutrient intakes (Hoey et al., 
2013). The above-mentioned evidence indicates the need to identify different dietary assessment 
methods that are appropriate for low-income groups. 
Table 5 shows the definitions and the proportion of low income and immigrants reported by 
Eurostat, the statistical office of the European Union, on foreign citizens in the EU27 Member 
States, EFTA and Candidate countries.  
----Please Insert Table 5 Here---- 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 75
Determinants of micronutrient inadequacy 
Dietary inadequacy can be observed in populations because of limitations of the measurements 
instruments, that affecting either the systematic or random errors (see above); in principle, such 
uncertainties should be bypassed by well-applied inclusion criteria (when existing data are used) 
or sufficiently standardised surveillance methodology (for future pan-European nutrition 
surveillance). For immigrants and low income/low SES groups additional considerations apply. 
Evaluating dietary intake of immigrant populations requires special attention to: 
 sampling and recruiting, instruments used, method of administration, food composition 
database, acculturation; 
 consumption in those eating from a shared serving dish/pot, understanding of food terms and 
concepts, scarce information on ethnic dishes and recipes, culture-specific foods and portion 
sizes; 
 language issues: the use of forward and back-translation is a widely used method in cross-
cultural research, and when combined with additional bilingual and monolingual post-
translation testing, it is considered as the most complete instrument translation process (Ngo 
et al.). 
Similarly, when assessing the dietary intake of low income / low SES groups, the following 
points require specific attention:   
 poor  motivation of the low income populations 
 variations in the level of language and numeric skills across the whole sample could induce 
difficulty in completing dietary records unless assistance is provided by either interviewers or 
other household members.  
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Four multiple-pass 24 h recalls were shown to be the most appropriate method for a study of diet 
and nutrition in low-income households (Vucic et al., 2009).  
Current evidence suggests that apart from income, there are other socioeconomic and cultural 
factors that influence micronutrient intake and/or status: education, occupation, employment, 
urbanisation, marital status, race/ethnicity.  
Therefore, EURRECA included education and occupation as two proxy key determinants of 
micronutrient intake and evaluated their association with differences in micronutrient intake 
and/or status. Methodology comprised a search in Medline and Embase to collect original studies 
that followed general EURRECA guideline on dietary intake and study characteristics (Activities 
1 & 3). 
For the evaluation of micronutrient adequacy in low SES groups there are several aspects to 
consider when analysing available data: i) existing evidence on micronutrient intake and/or status 
across different SES levels in Europe is scarce, especially for children and for all life stages in 
Central and Eastern Europe; ii) available publications differ in their categorisation of groups for 
indicator of interest (e.g: for education studies have stratified subjects within 2- 4 groups, for 
occupation 2-3, for income 2-4 groups); iii) studies applied different dietary intake instruments, 
etc. Figure 19 shows example result from this publication: mean intake of vitamin C in lowest 
and highest socioeconomic (SES) group in adults/elderly and children by different 
socioeconomic indicator, and in comparison to AR (Novakovic et al.). 
----Please Insert Figure 19 Here---- 
To overcome these methodological constraints and produce the results that are based on 
harmonised and comparable data, EURRECA has included additional work on evaluation of data 
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from two European projects, i.e. HELENA (www.helenastudy.com) and EPIC 
(www.epic.iarc.fr). Work on assessment of micronutrient intake in adolescents (HELENA) and 
adults and elderly (EPIC) in association with SES indicators is on-going and the results from 
these publications will be made available for supporting nutritional policy in Europe. 
Using dietary reference values in policy making: Identifying policy options (Activity 8) 
This activity describes the complex processes through which public health nutrition policy 
development is linked to micronutrient recommendations. 
The drive towards evidence based policy has been typified by: 1) a tendency to treat cost 
effectiveness and feasibility as key criteria for policy selection, as exemplified by a rise of health 
economics and impact assessments as evidence for policy; 2) a proliferation of frameworks and 
decision-making tools, usually linear in character, developed in order to increase evidence pull 
and utilisation through anticipatory problem-solving, planning and rational choice and often 
focused on developing  institutional forms that would act as bridges between research and policy 
communities (e.g. Scientific Advisory Bodies) (Lavis et al., 2009; Oxman et al., 2009).  
The need to expand the range of evidence that influences the preferred policy option has become 
apparent following a EURRECA case study based on folate recommendations (Timotijevic et al., 
2011a). It was shown that the link between DRVs, as the scientific evidence underpinning 
decisions about nutrition policies, and final policy action is not always made explicit and that the 
scientific advisory committee’s recommendation of mandatory food fortification with folic acid 
in order to achieve recommended intake is variably applied in policy across Europe (Timotijevic 
et al., 2011a).  
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Based on these observations, EURRECA has developed steps for decision making that link 
DRVs with the final policy action, depicted in figure 20. These steps correspond to some extent 
to the depiction of the linear model of RAF (MacKerras, 2012), though is more detailed about 
the range of considerations that are typically considered. It is developed with an aim of depicting 
the thinking requirements for linking DRVs and policy action. The choice of an appropriate 
public health nutrition policy option (or a combination thereof) is premised upon policy makers’ 
considerations of a range of evidence.  At the heart of the policy process is defining the policy 
goal and identifying appropriate policy action.  
----Please Insert Figure 20 Here---- 
Identify policy goals (e.g. health outcome) 
A public health nutrition policy goal can be framed as achieving a desirable or decreasing the 
risks of undesirable nutrition-related health outcomes. Key to identifying the policy goal is 
clarifying the strength, relevance and degree of uncertainty around the evidence linking nutrient 
intake to nutrient status as well as nutrient intake/status to a health outcome (Dhonukshe-Rutten 
et al., 2010b). This work is typically conducted by SABs resulting in a set of DRVs. These 
DRVs can provide reference points for adequate and optimal intakes for a population or sub-
population which can be combined with other sets of information (e.g. monitoring data from 
national nutritional surveys, advice from key stakeholders, over exposure data) and used (by the 
SAB, government or another body) to set nutrient/dietary recommendations and goals.  
Although nutrient intake is ultimately a nutritional measure, it is achieved through several food-
related behaviours that may include food choice, food storage, preparation and food occasions 
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(when and how it is eaten). Social & behavioural science provides useful insights into the hugely 
complex dynamic of food choice (Jensen et al., 2012). First, clarity about the contexts that define 
nutrient intake, which include the sources of the targeted nutrient, the targeted population and the 
availability of foods, is a necessary starting point in considering nutrient-relevant behaviours 
(and the range of policy options for behaviour change). It is also important to be clear about the 
kind of behavioural changes required to achieve a nutrient-relevant change - whether the nutrient 
intake needs to be increased or decreased - and to understand that the link between food and 
nutrient intake is complex since food choices are interrelated. The challenge is even greater when 
considering the intake of several nutrients. EURRECA have argued that moving beyond simple 
models of behaviour change to consider a range of behavioural mechanisms underpinning 
behaviour changes is an important step in unpicking   multiple influences on dietary behaviour 
(Jensen et al., 2012). 
Public health nutrition policy options relevant to micronutrient recommendations can broadly be 
divided into those that require voluntary behaviour change, those that incentivise or punish 
through economic means (awards/taxes), those that enforce a particular behaviour or choice (e.g. 
regulation through mandating fortification) and those which rely on collaborations (e.g. private-
public partnerships) and self-regulation (e.g. voluntary codes of conduct) (Timotijevic et al., 
2010a). Considerations of the key objectives of the existing policy, their timeline (both 
historically and in the context of further policy development and application), cost and who is 
involved in both the development and delivery of the policy are some of the key parameters of 
policy options selection (Kingdon, 2003). In addition, the key values for consideration of policy 
options - equity, efficiency, security and liberty - will be guiding principles of policy making. 
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Evidence derived from stakeholder participations is also sought to establish the dominant values 
for policy making. Table 6 below summarises some of the common policy options and ‘catalysts 
of change’ (the specific policy actions and interventions) in public health nutrition policy. In 
relation to public health nutrition policy social voluntary options (usually targeting general diet), 
and to a lesser extent regulatory policy options (usually targeting specific nutrients) are preferred 
policy options (see Table 7). 
There is a wider context to considerations that shape decision making. Ethical considerations are 
often invoked in deliberations of stakeholders about public health nutrition policy. Public 
participatory approaches or ethical reviews/consultations often engage in balancing the right to 
the autonomy of the individual in relation to food choice and consumption, with other principles 
(e.g. equity, social justice). The framing of the problem by the significant opinion leaders such as 
the media, think tanks or major NGOs is taken into account. Broader beliefs, values and practices 
are also a part of the wider context. Other important aspects of the evidence from the wider 
context include international (non-binding) guidelines and recommendations, global trends that 
are not directly related to public health nutrition (e.g. financial crisis) as well as technical 
capacities and infrastructure for the delivery of policy options. 
----Please Insert Table 6 Here---- 
Policy action is a product of iterative considerations of evidence within and across each of these 
steps. Final action will be selected from a number of options (see Table 6).  
Explicit and transparent process 
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EURRECA evaluated the step model of public health nutrition policy making (Figure 20) for its 
usefulness in capturing the actual processes of micronutrient–relevant policy decisions through: 
1. A workshop with key stakeholders with a view of refining the Steps of public health 
nutrition decision-making and scoping out the supporting materials and guidelines for the 
framework. 
2. Case studies (N=18)  based on triangulated evidence from interviews, desk research and 
the workshop to map the existing nutrition policy decision-making onto the Steps of 
public health nutrition decision-making 
The ideal of a rational-linear model of public health nutrition policy making (Figure 20), with its 
emphasis upon orderly consideration of different types of evidence is difficult to capturedoes not 
exist in practice. These findings are not new, it has been long acknowledged that the processes 
through which public policy is formed are exceedingly complex (Kingdon, 2003). In recognition 
of this, EURRECA has subsequently developed an alternative depiction of the process (Figure 
21). This Public Health Nutrition Policy Framework describes what considerations can influence 
the way in which nutrition policy goal – a desired health outcome - is linked to policy action. Its 
main premise is that a) contexts that form a backdrop of public health nutrition policy 
development vary and therefore the orderly stepwise approach is untenable and can hide the real 
influences upon policy decisions; b) the same type of evidence can be used to answer different 
policy-relevant questions and therefore it should not be tied to a specific step; c) questions 
relevant to each step can be addressed using a combination of evidence. The three sources of 
evidence are broadly defined as: Science, which includes both natural (e.g. nutrition/bio-medical, 
epidemiological) and social sciences (e.g. psychology, sociology); Institutions and Policy (which 
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includes e.g. evidence about regulatory frameworks, data on existing policy, governance 
networks); and Wider Context (which for instance includes international guidelines, wider 
ideology, ethics).  Unlike the linear model of RAF (MacKerras, 2012), the new representation 
simply classifies evidence into logical types and leaves it to the decision-maker to decide at what 
point and for what critical question they will source different evidence. The Public Health 
Nutrition Policy Framework (Figure 21) aims to support greater transparency through making 
explicit the sources of evidence in the complex process of decision-making from policy goal to 
policy action, without constraining the process to a linear format. 
---Please Insert Figure 21 Here--- 
Using dietary reference values in policy making: Evaluating policy implementation 
(Activity 9) 
Policy implementation and evaluation has been included here to acknowledge the role of 
micronutrient requirements in the wider public health nutrition context (research, policy and 
practice). The work of EURRECA centred upon the activities previously presented. However, a 
small number of EURRECA research findings were deemed relevant to policy implementation 
and evaluation. These have been detailed below to illustrate how data from this activity could be 
used to inform the selection of effective policy options, as well as feedback information on the 
need to review a policy or the micronutrient requirements themselves.  
Included below are descriptions of currently implemented policies and evaluation measures, as 
well as perceived barriers to policy implementation. For comprehensive data and guidelines on 
nutrition policy implementation and evaluation in Europe please see other European Commission 
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funded research projects, United Nations organisations or European Commission departments 
that have been recently active in this area e.g. The EATWELL project, the Directorate-General 
for Health and Consumers European - DG SANCO, UNICEF and WHO (Branca et al., 2009; 
Capacci et al., 2012; European Commission, 2010; Oxman et al., 2006; Trübswasser and Branca, 
2009; Traill et al., 2010). 
Current policies in Europe 
In 2007, EURRECA conducted a questionnaire survey with key informants representing 35  
European countries/regions (see Table 7 (de Wit et al., 2008). Each informant was asked to 
indicate the policies implemented in their country relevant to 20 pre-defined micronutrients using 
both open free format and closed multiple choice option questions. Results suggested that across 
a range of micronutrients the most frequently implemented policies were directed at the general 
diet rather than specific micronutrients. These took the form of social and voluntary policies, 
such as food-based dietary guidelines and general health education. Nevertheless, almost a third 
of those surveyed also implemented policies targeted at one or more of the following nutrients, 
namely calcium, folate, iodine, iron, sodium, vitamin A and vitamin D. These policy options 
included regulation and legislation, self-regulation and intervention short of legislation, for 
example, voluntary/mandatory fortification, supplementation and labelling programmes (de Wit 
et al., 2008; Dhonukshe-Rutten et al., 2010a). The policies implemented may differ between 
nutrients and countries/regions for many of the reasons previously discussed in Activities 1-8. 
For example a policy relevant to iodine was implemented in the majority of countries where 21 
out of 35 countries conducted voluntary/mandatory fortification (e.g. salt iodisation). It is likely 
this was due to the long standing coordinated scientific opinion and international action from 
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WHO, UNICEF and the non-governmental organisation of the ICCIDD to implement universal 
salt iodisation policies and eradicate iodine deficiency disorders (Hetzel, 2005). 
----Please Insert Table 7 Here---- 
Policy evaluation measures 
The questionnaire results in Table 7 identified nutrition monitoring and evaluation of nutrient 
inadequacy in a number of countries, particularly regarding iodine. These data from regular 
national or international monitoring surveys can act as policy evaluation measures and provide 
change data on disease incidence, health status, nutrient status or dietary intake data pre and post 
policy implementation to evaluate the impact of a policy. However, the EURRECA 
questionnaire data suggested that these measures were not always put in place: there were no 
nutrition monitoring or evaluation programmes implemented for any micronutrient in over half 
of the countries surveyed (see Table 7).  
An absence of policy evaluation measures or available evaluation data was also seen in further 
work by EURRECA. A systematic narrative literature review on food-based dietary guidelines 
(FBDG), found that although they were actively promoted as a viable public health nutrition 
policy there was little evaluation of FBDG effectiveness in terms of whether the general public 
used the guidelines (Brown et al., 2011).  Twenty-eight studies were reviewed which employed a 
variety of designs and methods to judge the awareness, understanding or use of FBDG by 
consumers (qualitative interviews, focus groups, field tests; quantitative questionnaire surveys 
and mixed methods experiments and questionnaire surveys). Some of these were far removed 
from a targeted health outcome or behaviour, such as the distribution of dietary education 
leaflets, posters or flyers (indicative of policy implementation rather than policy impact). This 
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work concluded that there was a degree of consumer awareness and understanding regarding 
FBDG, but there was little evidence to suggest consumer use of FBDG. However, more 
importantly the quality and quantity of the studies available for review was questioned and a 
paucity of available evaluation data highlighted.  
Barriers to policy implementation 
A series of qualitative studies using questionnaires, in-depth desk research, interviews or case 
studies (combination of either/or questionnaire, in-depth desk research and interview data), were 
conducted by EURRECA between 2007 and 2011 (for further study details please see the 
referenced publications). This work identified a number of possible barriers to policy 
implementation and evaluation.  
One study conducted 57 qualitative interviews with key informants, predominantly representing 
scientific advisory bodies and national governments, in ten European countries: the Czech 
Republic, Denmark, England, Germany, Greece, Italy, the Netherlands, Norway, Poland and 
Spain. Results suggested that budget or economic constraints were a major barrier to policy 
implementation. Furthermore, co-operation with and between organisations or institutions at a 
national level (e.g. government departments and all stakeholders - food industry producers, 
manufacturers, retailers and caterers, research centres, health professionals, consumer groups, 
media etc.), was viewed as crucial to the successful implementation of any policy. This was in 
terms of accessing a broad range of knowledge throughout the micronutrient requirement setting 
process to ensure the policy implementation was sufficiently planned as well as in terms of 
sharing resources, limiting conflict with existing policies and ensuring shared advocacy and 
support for a policy (Jeruszka-Bielak, in prep.). However, an additional EURRECA study 
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(Timotijevic et al., 2010a) suggested that the degree of stakeholders’ involvement prior to policy 
implementation and evaluation differed between countries (the Czech Republic, Denmark, 
Germany, Hungary, Norway, Spain and the United Kingdom). This appeared to be influenced by 
the historical, social, political context of the country (e.g. previous food crises such as variant 
Creutzfeldt-Jakob disease (vCJD/nvCJD) the human prion disease caused by bovine spongiform 
encephalopathy (BSE) in the UK led to formalised stakeholder involvement throughout nutrition 
decision-making processes).  
 Conclusions 
A process for deriving and using micronutrient requirements comprising nine activities grouped 
in four stages (i) defining the problem, (ii), monitoring and evaluating iii) deriving dietary 
reference values and (iv) using dietary reference values in policy making has been presented. 
The framework is meant to be comprehensive and includes an exhaustive list of activities that 
should if at all possible be used for deriving dietary reference values and for providing the 
evidence-base for policy making (Table 8). The framework should not to be regarded as a 
prescriptive description of a linear process. The circular nature of the diagram indicates that it is 
a continuous and interactive process in which all the stages are interlinked and have the potential 
to feed into each other. The central position of the “monitoring and evaluation” stage 
communicates that dietary assessment methodology and nutrition surveillance data are crucial to 
both the definition of the problem (i), as well as to deriving reference values (iii), and to 
proposing and evaluating policies (iv). 
The first activity defines the nutrition-related health problem in terms of i) relevant health 
outcomes, ii) specific population groups, and iii) the micronutrient of concern. This results in a 
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prioritisation of the micronutrients which is resulting from the availability of new scientific 
evidence, public health relevance and heterogeneity of current reference values. In Activity 2 the 
process by which dietary reference values are derived and applied is established and usually 
involves bringing together a Scientific Advisory Body (SAB) to provide national and 
international credibility and expertise relevant to the problem to be addressed. The SAB has to 
acknowledge that, due to the pressure for scientific consensus, the difficulty of dealing with 
scientific uncertainty in policymaking contexts, unanimity in communicating findings and the 
inherently political nature of SAB (as a bridge between science and policy), are particular 
challenges in efforts to increase transparency of scientific advice to policymakers relevant to 
micronutrient DRVs.  
----Please Insert Table 8 Here---- 
As mentioned in Activity 3, monitoring the intake and status of certain micronutrients and 
related health endpoints requires the use of best practice methodologies, definitions and 
terminologies. In fact, the ‘Monitoring and evaluating’ stage is relevant to all stages in the 
diagram. The information derived from monitoring the intake, status and health situation in 
European countries or populations provides input to the priority setting (Stage ‘Defining the 
problem’) and refers to inadequacies and public health problems. Moreover, evaluation measures 
provide the basis for the policy options and implementation as well. This includes inadequacies 
based on monitoring data. Activity 7 ‘Nutrient intake & status of population groups’ in particular 
focusses on evaluation relevant to ‘Using dietary reference values in policy making’ and then 
closes the loop to ‘Defining the problem’. 
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The stage ‘Deriving dietary reference values’ consist of three sequential activities i.e. activities 4, 
and 6. A variety of sources of evidence is used to derive dietary micronutrient requirements. The 
availability of data from different types of study influences whether the ‘factorial’ or ‘dose 
response’ approach is adopted in the derivation process. Activity 4 ‘Sources of evidence’ 
describes a harmonised and standardised approach for the identification and collation of robust 
data which is indispensable for the elimination of current disparity in the evidence base for 
micronutrient recommendations. The strength of this approach is that data identification, 
collation and ultimately analysis can be achieved in a transparent manner. The process can be 
tailored with relevance to specific population groups and micronutrients and for data to be used 
in both the factorial and dose response approach. Activity 5 ‘Appraisal of the evidence’ involves 
interpreting the data by means of quantitative or qualitative analysis, assessing the quality of the 
data, and including certain elements of judgement which will result in a qualitative scientific 
conclusion. This conclusion will inform decision-makers about which data could be used for the 
definition of micronutrient requirements. Activity 6 ‘Integrating the evidence’ involves the 
quantification and integration of both factorial and dose response approaches into average 
requirements (ARs) including the derivation of the variation in requirements. Eventually, 
reference values for micronutrient intake for specified proportions of the population (resembling 
the definition of AR and PRI) can be derived from bivariate or trivariate models once thresholds 
on the health or status variable are set. 
Finally, as described in Activities 8 and 9 (Stage ‘Using dietary reference values in policy 
making’), policy decisions regarding the implementation of nutrient recommendations need to be 
made and include the need for an understanding of food related behaviour and other relevant 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 89
evidence needed for developing public health nutrition policy. The framework for considering 
evidence in public health nutrition policy development that was developed within EURRECA 
can be used for as a checklist for the types of evidence that routinely enter decision making. 
It is important to note that the different activities can be conducted by different bodies. The 
extent to which each stage will be dealt with comprehensively will depend on the time, resources 
(including expertise available) and information available in the country or region. It may be the 
case that some of the activities need not be carried out in full in a particular country or region if it 
is felt that these have already been adequately dealt with on a previous occasion, e.g. decisions to 
go with previously established information or the adoption of decisions from other bodies. 
Where organisations choose to draw on activities carried out elsewhere the framework can act as 
a check list to ensure all important matters have been addressed. The framework can serve as a 
structured guide for safeguarding that all issues essential for deriving requirements have at least 
been considered. Limits on resources, available time and available information will shape the 
scope of work a given body can take on decisions will need to be taken as what can be regarded 
as the most relevant and urgent activities. 
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Health outcomes studied for the micronutrients which were reviewed within the framework of 
EURRECA for different life-stage groups. 
Micronutrient Population EURRECA databases Outcomes studied 
Iron 
Infants 1-2 Growth 
Neurodevelopment 
Children & 
Adolescents 3-6 
Immune function 
Cognitive functions & psychomotor 
development 
Pregnant & 
lactating women 7-8 
Fetal growth (Fetus) 
Preterm delivery (Fetus) 
Preeclampsia (Mother) 
Postpartum depression (Mother) 
Adults & elderly 9-18 
Tiredness 
Physical performance 
Immune function 
All population 
groups 19-20 
Polymorphisms 
Bioavailability 
Zinc 
Infants 21-22 
Growth 
Immune response to vaccination 
Neurodevelopment 
Children & 
Adolescents 25 
Growth 
Immune function 
Cognitive functions & psychomotor 
development 
Dermatitis 
Pregnant & 
lactating women 23-24 
Fetal growth (Fetus) 
Fetal malformation (Fetus) 
Preeclampsia (Mother) 
Preterm delivery (Mother) 
Adults & elderly 26 
Immune function 
Cognitive function 
Dermatitis 
All population 
groups 27-31 
Polymorphisms 
Bioavailability 
Folate Infants 32-33 & 45 Growth Folate-deficiency anaemia 
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Children & 
Adolescents 34-35 & 46-47 
Cancer (DNA synthesis) 
Folate-deficiency anaemia 
Immune function 
Cognitive functions & psychomotor 
development 
Pregnant & 
lactating women 43-44 & 48 
Fetal malformations (Fetus) 
Fetal growth  (Fetus) 
Maternal macrocytic anemia 
(Mother) 
Preeclampsia (Mother) 
Preterm delivery (Mother) 
Placental abruption (Mother) 
Adults & elderly 36-42 
Stroke 
Cancer 
Osteoporosis 
Cognitive function* (Cognitive 
function test score like MMSE, AD, 
depression,...) 
All population 
groups 49 Factorial 
Vit B12 
Infants 50-51 Neurodevelopment Megaloblastic anemia 
Children & 
Adolescents 52-53 
Megaloblastic anemia 
Growth 
Cognitive functions & psychomotor 
development 
Pregnant & 
lactating women 54-55 & 61 
Fetal malformations (Fetus) 
Fetal growth (Fetus) 
Megaloblastic anemia (Mother) 
Preeclampsia (Mother) 
Adults & elderly 56-57 & 60 
Anemia** 
Nervous system disease*** 
Cognitive funtion**** 
Osteoporosis 
All population 
groups - 
polymorphism 
58   
All population 
groups - 
absorption 
59   
Selenium Adults & elderly 62-63 Male fertility 
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Cognition in elderly populations 
Immune function and infection within 
populations ≥ 50 years old 
disease progression and status within 
HIV+ patients/populations 
All population 
groups - 
polymorphism 
64   
All population 
groups - 
absorption 
65   
Iodine 
All population 
groups 
(including low 
income & 
immigrants) 
66-67   
Riboflavin Adults & elderly 68   
* As cognitive function will be covered only once, the 3 primary health outcomes are done  
** There are 4 types of anemia associated with vit B12 deficiency: megaloblastic anemia, 
pancytopenia, thrombocytopenia and leucopenia 
*** The most important manifestations related to b12 are: peripheral neuropathy, degeneration 
of the spinal cord and ataxia 
**** The most important manifestations include: dementia, depression, Alzheimer’s disease, 
psychosis 
Supplementary document 2 
Basic mathematical network model of multiple micronutrient involvement in the 
inflammatory process.  
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Abbreviations of immune response markers: α-1-ACT: alpha-1-antichymotrypsin; CRP: C-
reactive protein; IL: Interleukin; PGE2: prostaglandin E2; PGF2a: prostaglandin F2a; TNFα: 
tumor necrosis factor alpha; TNFαR2: tumor necrosis factor alpha receptor 2; VCAM: vascular 
cellular adhesion molecule; WBC: white blood cell. Abbreviations for micronutrients: B6, B12, 
C, E: respective vitamins; b-Car: beta-carotene; Cu: copper; Fe: iron; Mg: magnesium; Se: 
selenium; Zn: zinc. 
This micronutrient-inflammation model highlights the interactions of a multitude of 
micronutrients on immune parameters relevant for health status. Significant correlations between 
micronutrient and inflammation markers are depicted by blue arrows with a + sign reflecting a 
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direct correlation or red arrows with a – sign reflecting an inverse correlation. As an example, 
plasma concentrations of C-reactive protein (CRP), a marker of chronic inflammation, which is a 
risk indicator for development of cardiovascular disease, have been shown to be positively 
correlated with plasma concentrations of iron (Fe), copper (Cu), vitamins B6, B12, and C, and 
negatively correlated with beta–carotene (b-Car), folate, magnesium (Mg), selenium (Se), and 
vitamin E concentrations. Similarly, it can be deduced that, in addition to its effect on CRP, 
vitamin C positively affects plasma levels of pro-inflammatory mediators prostaglandin E2 
(PGE2), and tumor necrosis factor alpha (TNFα), whereas it is negatively correlated with plasma 
nitric oxide (NO) levels. This model clearly demonstrates that multiple micronutrients interact at 
different points in the inflammatory health response, and this knowledge could enable the 
selection of relevant micronutrient related health status parameters that may feed into the 
recommendation process based on optimized statistical methods such as those supporting the 
‘health space’ concept. This latter approach has been discussed further in Activity 6. 
Supplementary document 3 
Assessment of internal validity in RCTs, Cohort and Cross sectional studies 
Lee, Adrienne, Rosalie, Rachel and Linda, 23rd June  2010 
At the end of data extraction, for each study we have a set of indicators of internal 
validity. The internal validity focuses on the quality of the study and tells us something 
about the risk of bias.  We know: 
 Methodology (RCT, cohort, case control) 
 Something about various indicators of internal validity (which vary from 
methodology to methodology) 
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Randomised controlled trials (RCTs) 
For each review question we need to print out the table of internal validity 
characteristics for all of the RCTs, for all of the cohorts and for all of the cross sectional 
studies.  We should be able to print this table directly from the data extraction database 
(Adrienne will help you to do this for each study methodology).  A sample table for an 
RCT data set is printed below (your basic output table may need some neatening up to 
make it look good and read well).  For each table the columns with black and purple 
headings will already be completed, the columns with blue headings will need to be 
completed independently in duplicate by 2 reviewers and then checked.  In your 
methodology you will need to state how any disagreements were decided. 
RCT validity 
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The criteria for judging the coloured headings (those in purple, and those in blue) are 
below, and are adapted from the Cochrane Handbook (General reading is 'Chapter 8: 
 Assessing risk of bias in included studies' in the Cochrane Handbook, available freely 
on line)1. 
 SEQUENCE GENERATION (1) complete during data extraction 
Was the allocation sequence adequately generated? [Short form: Adequate sequence 
generation?]  
Criteria for a judgement 
of ‘YES’ (i.e. low risk 
of bias). 
The investigators describe a random component in the sequence 
generation process such as: 
 Referring to a random number table; 
 Using a computer random number generator; 
 Coin tossing; 
 Shuffling cards or envelopes; 
 Throwing dice; 
 Drawing of lots; 
 Minimization*. 
 *Minimization may be implemented without a random element, and 
this is considered to be equivalent to being random. 
Criteria for the 
judgement of ‘NO’ (i.e. 
high risk of bias). 
The investigators describe a non-random component in the sequence 
generation process. Usually, the description would involve some 
systematic, non-random approach, for example: 
 Sequence generated by odd or even date of birth; 
 Sequence generated by some rule based on date (or 
day) of admission; 
 Sequence generated by some rule based on hospital or 
clinic record number. 
                                               
1
 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The 
Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org. 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 98
  
Other non-random approaches happen much less frequently than the 
systematic approaches mentioned above and tend to be obvious.  
They usually involve judgement or some method of non-random 
categorization of participants, for example: 
 Allocation by judgement of the clinician; 
 Allocation by preference of the participant; 
 Allocation based on the results of a laboratory test or a 
series of tests; 
 Allocation by availability of the intervention. 
Criteria for the 
judgement of 
‘UNCLEAR’ 
(uncertain risk of bias). 
Insufficient information about the sequence generation process to 
permit judgement of ‘Yes’ or ‘No’.  
 
ALLOCATION CONCEALMENT (2) complete during data extraction 
Was allocation adequately concealed? [Short form: Allocation concealment?] 
Criteria for a 
judgement of ‘YES’ 
(i.e. low risk of bias). 
Participants and investigators enrolling participants could not foresee 
assignment because one of the following, or an equivalent method, was 
used to conceal allocation: 
 Central allocation (including telephone, web-based, and 
pharmacy-controlled, randomization); 
 Sequentially numbered drug containers of identical 
appearance; 
 Sequentially numbered, opaque, sealed envelopes.  
Criteria for the 
judgement of ‘NO’ (i.e. 
high risk of bias). 
Participants or investigators enrolling participants could possibly foresee 
assignments and thus introduce selection bias, such as allocation based 
on:  
 Using an open random allocation schedule (e.g. a list of 
random numbers); 
 Assignment envelopes were used without appropriate 
safeguards (e.g. if envelopes were unsealed, not opaque 
or not sequentially numbered); 
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 Alternation or rotation; 
 Date of birth; 
 Case record number; 
 Any other explicitly unconcealed procedure. 
Criteria for the 
judgement of 
‘UNCLEAR’ 
(uncertain risk of bias). 
Insufficient information to permit judgement of ‘Yes’ or ‘No’. This is 
usually the case if the method of concealment is not described or not 
described in sufficient detail to allow a definite judgement – for example 
if the use of assignment envelopes is described, but it remains unclear 
whether envelopes were sequentially numbered, opaque and sealed. 
Cohort and nested case control studies 
Basic reading on assessment of validity in cohort studies is section '13.5  Assessing risk 
of bias in non-randomized studies' from the Cochrane Handbook, available freely 
online2.  
When data extracting:  
 'Dissimilarity of most and least exposed...'  here note the confounders from the list 
above that were similar at baseline  
 'Where dissimilar at baseline, were there adjustments for these factors...' here 
note the confounders from the list above adjusted for or dealt with (for example, by 
matching of participants eg according to socioeconomic status and age, or exclusion 
eg of smokers) in the analysis (under 'clarify') 
 'Were measurement errors in exposure and outcome taken in to account...'  Method 
of assessment of intake or status noted 
Cohorts and nested case control studies: 
                                               
2 2Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The 
Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org. 
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Blue coloured columns are filled in after data extraction and once the table is created 
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(not during data extraction), while columns in black text are taken directly from data 
extraction forms (see Adrienne for how to do this). 
Blue coloured columns are filled in after data extraction and once the table is created 
(not during data extraction), while columns in black text are taken directly from data 
extraction forms (see Adrienne for how to do this). 
Cross sectional studies 
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e
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 Overall risk of bias for cross sectional studies complete in table (11)  
This is an overall summary of the various issues for this study 
Criteria for a 
judgement of 'Cross-
sectional, low risk of 
bias’. 
  Where there are no important confounders not dealt with 
appropriately, and assessment of exposure and funding are 
both adequate, and there are no serious risks of bias in the 
other areas: the risk of bias is low 
 
Criteria for the 
judgement of ‘Cross-
sectional, moderate 
risk of bias). 
There is only one important risk of bias. Any ONE of the following may 
be "inadequate" or "unclear":  
 One important confounder was not dealt with appropriately 
(if more than one confounder then the study is at high risk) 
 Assessment of exposure 
 Funding  
 There is one serious risks of bias in another area 
Criteria for the 
judgement of ‘Cross-
sectional, high risk of 
bias). 
There is more than one important risk of bias. More than ONE of the 
following may be "inadequate" or "unclear":  
 One important confounder was not dealt with appropriately 
(any confounder not dealt with counts as an additional bias) 
 Assessment of exposure 
 Funding  
 There is one serious risks of bias in another area 
Supplementary document 4 
Estimation of single summary estimates (beta’s) and the overall pooled estimates 
The transformations used to derive coherent single-study estimates from the available summary 
statistics per study have been described by Souverein et al (2012). In short, the estimation of an 
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intake-status regression coefficient (β) for each individual study, is based on the assumption of a 
linear relation on the loge-loge-scale (natural logarithm of intake versus natural logarithm of 
status). Algebraically deriving an estimate from each study of the regression coefficient ( ) and 
its standard error (SE( )) enables to compare the results from studies with heterogeneously 
reported associations and effects. 
Then, the overall pooled   and SE( ) are calculated by using random effects meta-analysis, 
which estimates the between-study variance using the method of DerSimonian and Laird and 
then use this estimate to modify the weights used to calculate the summary estimate. Residual 
heterogeneity between studies was evaluated using the I2 statistic. Pre-specified potential factors 
that could modify the association should be explored using stratified random effects meta-
analyses. The statistical transformations to obtain ’s and SE( )’s can be performed using 
GenStat version 13-SP2 (VSN International Ltd., http://www.vsni.co.uk/) and the meta-analysis 
can be performed using STATA version 11.0 (College Station, TX), with statistical significance 
defined as P<0.05 (Dullemeijer et al., 2012). 
Dullemeijer, C., Souverein, O. W., Doets, E. L., Van der Voet, H., Van Wijngaarden, J. P., de 
Boer, W. J., Plada, M., Dhonukshe-Rutten, R., In 't Veld, P. H., Cavelaars, A. E., De 
Groot, L. C. P. G. M., and Van `t Veer, P. (2012). Systematic review with dose-response 
meta-analyses between vitamin B12 intake and EURRECA's prioritized biomarkers of 
vitaming B12 including randomized controlled trials and observational studies in adults 
and elderly. American Journal of Clinical Nutrition. 
Souverein, O. W., Dullemeijer, C., van, T. V. P., and van der Voet, H. (2012). Transformations 
of summary statistics as input in meta-analysis for linear dose-response models on a 
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logarithmic scale: a methodology developed within EURRECA. BMC Med Res 
Methodol. 12: 57. 
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Table 1: Key characteristics of the case studies to examine the processes of establishing 
micronutrient DRVs 
 
1 Part of the case study for vitamin D was based on Denmark as a representative of the Nordic 
countries 
 
 
 
 
 
 
Three micronutrients known for a recent 
or past history of policy debates 
Folic acid, Iodine,  Vitamin D1 
Countries representing different 
institutional contexts and a north-south 
gradient in Europe 
Czech Republic, Italy, Netherlands, Nordic 
countries (Denmark, Finland, Iceland, Norway, 
Sweden), Poland, Spain 
Quantitative and qualitative methods 
allowing triangulation 
Quantitative and qualitative online questionnaire (de 
Wit et al 2008) 
Qualitative interviews  (de Wit in preparation, 
Jeruszka-Bielak in preparation) 
In-depth desk research 
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 Table 2 Composition of Scientific Advisory Bodies in Europe: fields of expertise 
 
* Denmark, Finland, Iceland, Norway, Sweden 
Country N of members Selection criteria 
Fields of Expertise 
Nutri
tion 
Public 
health/ 
Epidemi
ology 
Medi
cine 
Bio/ 
chem
istry 
Risk 
assess
ment 
Food 
techno
logy 
Czech 
Republic 
8 (self-
selected) 
Individual expertise 
● 
  
● ● 
 Specific sector 
Italy 4 working 
groups 
(8-10 
members 
each) 
Individual expertise 
● ● ● ● 
 
● Institutional authority 
Specific sector 
Netherlands 38 Individual expertise 
(independent experts) ● ● ● ●   
Nordic 
countries* 
30 
(selected 
by 
governme
nts) 
Individual expertise 
(scientific) 
● ● ● ● 
  Institutional authority 
Poland 5 Individual expertise 
(experience) 
● 
 
● ● 
  
Institutional authority 
(long-term employment) 
Specific sector 
Spain 3 Individual expertise 
● 
     Institutional authority 
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Table 3 Bodies responsible for public health nutrition policy in Europe 
Country Body Responsible Type of Body 
Czech Republic Ministry of Health, Department of Public Health, supported 
by the Scientific Committee for Food - iodine 
Governmental, working group for iodine 
Italy Italian Society of Human Nutrition (SINU), supported by 
the National Research Institute on Food and Nutrition 
Nutrition society (scientific with links to 
governmental bodies) 
Netherlands Ministry of Health, supported by The National Health 
Council (TNHC) 
Governmental, TNHC is an independent 
scientific advisory body 
Nordic countries  Nordic Committee of Senior Officials on Food Issues, EK-
Livs., supported by the Working Group on Diet and 
Nutrition (NKE)  
Project group nominated by NKE 
Poland Ministry of Health, supported by the National Food and 
Nutrition Institute, Warsaw 
Governmental 
Spain Madrid University and Spanish Society of Community 
Nutrition (SENC) 
Nutrition society, expert group 
* Denmark, Finland, Iceland, Norway, Sweden 
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Table 4. Approaches and study types used to derive micronutrient requirements (adapted from 
Matthys et al (2011)) 
Approach* Outcome 
Measures Study type Principle of method Study design 
Applicable 
population 
group 
F 
A 
C 
T 
O 
R 
I 
A 
L 
Physical 
or 
metabolic 
outcome 
Metabolic 
balance studies 
at various intake 
levels 
Long-term 
intake = Long 
term losses 
Requirement: 
intake level at 
which balance 
(stable body 
pool, rate of 
absorption & 
excretion) 
cannot be 
maintained. 
Cross-
sectional & 
prospective 
All age 
groups 
Growth studies, 
biochemical 
studies 
Rate of 
accumulation 
of nutrients in 
the body 
(foetus, 
placenta, etc.), 
breast milk 
composition 
& volume 
Cross-
sectional & 
prospective 
Foetus, 
infants, 
pregnant 
and 
lactating 
women 
D 
O 
S 
E 
- 
R 
E 
S 
P 
O 
N 
S 
E 
Health 
outcome 
Depletion / 
repletion studies 
Symptoms 
occur in 
response to 
dietary 
insufficiency 
& alleviate 
with 
sufficiency 
RCT Young adults 
Biochemical / 
biological 
studies 
Identification 
of subclinical 
deficiencies or 
reduction/lack 
of function in 
relation to 
specific 
micronutrient 
RCT & cross-
sectional 
All age 
groups 
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Epidemiological 
studies 
Identification 
of (chronic) 
diseases 
(functional 
outcomes) 
Observational, 
interventional 
Adults, 
elderly 
*The factorial approach relies on measurements of a variety of factors including requirements for 
growth, pregnancy and lactation and faecal and urinary losses that determine requirements to 
maintain plasma levels or body stores resulting in normal tissue and body function and 
prevention of adverse health effects (Reference values derived by this approach also rely on the 
application of a bioavailability factor) to convert the physiological requirement into a dietary 
intake value.  
The dose response approach is based on the prediction of a physiologically relevant outcome 
which could be the measurement of an accepted micronutrient status biomarker in response to 
dietary intake, or the assessment of clinical disease endpoints in relation to intake or status. 
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Table 5 Low social class and immigrant: definitions and proportion in EU27 Member states 
Population groups vulnerable to micronutrient inadequacy 
Low social class : 
According to Eurostat definition population in or at risk of poverty comprises all persons 
with disposable income, adjusted for family size, i.e. equivalised income, that is below 60 
percent of the median national value in each year. Within the European Union (EU- 27 
member countries), there are 16% (80199 thousands persons) that are in or at risk of 
poverty. It ranges from 9% in Czech Republic to 22% in Romania. 
Immigrants: 
The total number of non-nationals (people who are not citizens of their country of 
residence) living on the territory of an EU Member State on 1 January 2010 was 32.5 
million persons, representing 6.5 % of the EU-27 population. However, more than one 
third (a total of 12.3 million persons) of all non-nationals living in the EU-27 on 1 
January 2010 were citizens of another EU Member State. 
(source : www.ec.europa.eu) 
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Table 6 Examples of nutrient related policy options (draws on definitions outlined in Ledbury et al (Ledbury et al., 
2006)). 
Policy type Policy instrument for 
implementation 
Examples  
Social 
voluntary 
Publications  Multiple countries: Food-based dietary guideline messages and 
food guides Campaigns  Czech Republic: 6th March iodine day  
Labelling  Multiple countries: Back of pack nutritional information 
Advisory service  Multiple countries: training & advice provided to health 
professionals to disseminate to the public 
Representation service  An expert is appointed to act on behalf of a person or business, e.g. 
Ombudsman 
Economic Taxation  Multiple countries: tax rate differences between healthy and 
unhealthy foods 
Charges  Government charges for services that are consumed* 
Subsides and vouchers UK: Healthy Start programme – vouchers to swap for 
Tax credits The government reduces the cost of an activity* 
Benefits & grants  Finland: Free school meals 
Award auctioning of franchises 
and licences 
Systems under which the right to produce a 
Government loans, loan 
guarantees and insurance  
Government provides loans and/or a subsidy (e.g. through 
guarantees or insurance)* 
Regulation 
& legislation 
Price & market structure 
regulation  
Denmark: Fat-tax 
Production and consumption 
regulation  
Denmark: Mandatory table & bread salt iodisation; Poland: 
Mandatory infant formula fortification 
Standard setting regulation  UK: Nutrient profiles for “traffic-light” nutrition labelling 
Prescriptions & prohibition 
legislation  
France and UK: Banning of school soft drink dispensers 
Rights and representation 
legislation  
 Rules which provide agents with rights and/or 
Self-
regulation 
Voluntary agreement Spain: Voluntary fortification of low fat milk and milk products 
with vitamin D 
Codes of practice  UK: Health Food Code of Good Practice (Food & Drink Industry) 
Co-regulation  UK: OFCOM (communications regulator) rules 
Intervention 
short of 
legislation 
Goal setting EU Platform for Action on Diet, Physical Activity and 
Infrastructure provision  Multiple countries: urban development for health, e.g. urban 
farming 
* Not currently directly related to nutrition 
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Table 7 Reported policies implemented relevant to micronutrients in the thirty-five countries 
surveyed in 2007 (n countries, if ≥ 9). 
 
 
 
Micronutrient General health education FBDG Monitoring & evaluation Specific health 
education Fortification Supplementation Labelling Vol. action Task force 
Vitamin A 14 12 9  10  9   
Vitamin D 13 13 9  10 14    
Vitamin E 12 11        
Vitamin C 13 13 9       
Thiamin  12 10        
Riboflavin 11 10        
Niacin 11 9        
Vitamin B6 11 10        
Folate 14 13  13  13    
Vitamin B12 11   11      
Sodium 16 15 9 11   11 15  
Potassium 11 10        
Calcium 14 13 9 10      
Magnesium 10 10        
Iron 15 12 9 10  10    
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Zinc 10 9        
Copper 10 9        
Phosphorus 10 9        
Selenium 10 9        
Iodine  18 15 11 9 21    9 
FBDG - food based dietary guidelines; Monitoring & evaluation - monitoring and evaluation of 
nutritional intake/status; Vol. action - inducing voluntary action in industry; Task force - setting 
up a task force. Thirty-five countries surveyed: Albania; Austria; Belgium; Bosnia and 
Herzegovina, Federation of Bosnia and Herzegovina1; Bosnia and Herzegovina, Republika 
Srpska1; Bulgaria; Croatia; Czech Republic; Denmark; Estonia; Finland; France; Germany; 
Greece; Hungary; Iceland; Ireland; Italy; Latvia; Lithuania; Montenegro; Netherlands; Norway; 
Poland; Portugal; Romania; Russian Federation; Serbia; Slovakia; Slovenia; Spain; Sweden; 
Switzerland; The former Yugoslav Republic of Macedonia; United Kingdom. 1Bosnia and 
Herzegovina are politically decentralised with two governing entities: the Federation of Bosnia 
and Herzegovina and Republika Srpska  
Table adapted from  de Wit et al., 2008 
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Stage Activities Activity topics 
Defining the 
problem 
Identifying the nutrition-related 
health problem (1) 
 Health outcomes 
 Population groups 
 Micronutrients 
Defining the process (2) 
 Scientific Advisory Bodies 
 Risk assessment and risk 
management 
 Communicating findings to 
policy decision-makers 
Monitoring and 
evaluating 
Establishing appropriate 
methods (3) 
 Assessment of dietary 
micronutrient intake 
 Assessment of micronutrient 
status 
Nutrient intake & status of 
population groups (7) 
 Assessing dietary intake and 
nutritional status 
 Assessing health status 
reflecting the nutritional status 
 Identifying vulnerable groups 
 Determinants of micronutrient 
inadequacy 
Deriving dietary 
reference values 
Collating sources of evidence (4) 
 Systematic data collection 
 Factorial approach & 
bioavailability 
 Dose-response approach 
 Inter-individual variability 
Appraisal of the evidence (5) 
 Study design: observational 
studies & RCTs 
 Evaluation of heterogeneity 
 Overall quality of the evidence 
Integrating the evidence (6) 
 Quantification 
 Expert consultation 
 Factorial & bioavailability 
approach 
 Dose-response model 
 Scaling of ARs to other 
population groups 
 Biological modelling for 
multiple micronutrients 
Using dietary 
reference values in 
policy making 
Identifying policy options (8) 
 Identify policy goals 
 Evaluate evidence 
 Select appropriate policy action 
 Explicit and transparent process 
Evaluating policy 
implementation (9) 
 Current policies in Europe 
 Policy evaluation measures 
 Barriers to policy 
implementation 
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Table 8 Overview of the EURRECA stages, activities and topics dealt with in each activity 
 
 
Figure 1 Final EURRECA framework describing the process for setting micronutrient 
requirements. The framework includes 9 activities that have been clustered in four different 
stages. 
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Figure 2 Two concepts which both provide scientific evidence for setting nutritional reference values: Factorial approach (left), Dose response approach (right). The factorial approach estimates losses and needs for maintenance and growth by actually measuring the 
various (exchanges between) body pools, which usually requires advanced methods in selected study groups. The results lead to Adequate Intake levels, unless a critical pool size has 
been established. The dose response approach addresses depletion-repletion studies, RCTs and 
observational studies covering a wide dose range. When a health criterion can be specified and the data allow extrapolation of the dose response curve to the lower end of the intake range, an AR can be estimated as well (see activity 6).usually addresses nutritional 
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requirements to prevent a critical clinical outcome and leads to an AR but often requires highly selected study groups. For the dose response approach, health outcomes are usually available from observational and intervention data in general population groups; these data can be used to estimate Adequate Intakes. Moreover, when a health criterion can be specified and the data allow extrapolation of the dose response curve to the lower end of the intake range, an AR can be estimated as well (see activity 6). (Figure available in color online)    
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Figure 3 Prioritizing micronutrients for the purpose of reviewing their requirements: a protocol 
developed by EURRECA (Cavelaars et al., 2010). 
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Figure 4 Abbreviated EURRECA decision tree for evaluation of robust dietary intake data 
suitable for epidemiological studies to assess associations between dietary intake and health 
outcomes. 
 
 
 
 
 
Diet record or 24h recall 
based on at least 3d (not 
necessarily consecutive)?
INCLUDE
Was an FFQ used?
Was intake of 
supplements recorded? 
(unless intentionally 
excluded in study design)
Was the FFQ validated?
EXCLUDE
NO
NO
NO
NO
NO
YES
YES
YES
YES
EXCLUDE
Was intake of 
supplements recorded? 
(unless intentionally 
excluded in study design)
NO
YES
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Abbreviations: Household budget Survey (HBS), Food composition database (FCDB); Figure 
adapted from García-Alvarez et al, 2009 
 
Figure 5. Summary Best Practice Guidelines on Nutrient Intake Assessment for selecting the best 
available nutritional intake survey/study per country.  More details on the methods and tools can 
be found under section “Assessment of dietary micronutrient intake” in the current manuscript.   
 
& 
& 
 
 
 
               Select only one survey/study per country with the following characteristics: 
 
 
 
 
 
 
       
“Ideally” select surveys/studies that are: 
 
 
 
 
                                                If not available, select                              If not available, select 
 
 
 
 
 
 
              By population group 
 
  
& 
 Cross-sectional design 
 Most representative of the country’s population (external validity) 
 Most recent (of those conducted after 1990) 
 With the best methodology (internal validity) 
From the pool of dietary surveys/studies obtained through country experts (questionnaire only): 
 
First. Regional 
Second. Local 
First. Health with nutritional data 
Second. HBS with nutritional data 
Nutritional 
 
National 
 
Toddlers 
 
Infants 
 
Children 
 
Adolescents 
 
Adults (18-65 years) 
 
Elderly 
 
Exclude other 
combinations 
Variables considered in the quality analysis (in priority order) 
 
 Diet assessment methods: Instruments (methods combinations), data collection techniques (three to four options), adequacy assessment (yes/no, methods 
combinations). 
 Validation (yes/no) 
 FCDB including functional & fortified (yes/no). 
 Under-reporting excluded/considered (yes/no). 
 Others: - supplements included (yes/no), functional & fortified included (yes/no), physical activity assessment (yes/no, three assessment methods), 
anthropometric measurements (yes/no, weight/height, measured/self-reported). 
 Year: 1990 – 1999, 2000 – 2004, 2005 & over. 
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Factorial 
approach
Dose response based on 
RCTs and epidemiological studies or 
factorial approach
Factorial approach
A
ve
ra
ge
R
eq
ui
re
m
en
t
‘Population groups’ / age
Pregnancy & lactation
Birth
Infants Children and adolescents Adults, postmenopausal women
Older people
Fetal growth
Shape of curve : 
scaling issue 
(“extrapolation”)
Factorial 
approach
 
Figure 6  Conceptual representation of average requirements (AR) for micronutrients as a 
function of age (relative to population groups and age across the life cyclespan). The figure  
highlightsing the widely different types of evidence and research approaches and scaling 
methods that underlie the derivation of ARs. This illustrates the need of standardisation of 
methods and weighing the different types of evidence. se data. Conceptualisation of the evidence 
base for average requirements according to age and life stage with scientific approaches 
generally used to derive these recommendations  
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Figure 7 Generalised systematic review process for identification of data relevant to the 
derivation of dietary recommendations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER library 
(all search 
EMBASE  
search 
MEDLINE 
search  
COCHRANE 
search 
Screening 10 
% duplicate 
assessment 
Screening  
100% by 
review team 
Conduct database searches 
for each micronutrient  
 
Screen search 
results on the 
basis of titles 
and abstracts 
 
Collection of papers and 
assessment on the basis of 
full-text,  
 
Data extraction of final 
included papers 
 
Meta-analysis and modeling 
of data 
 
Full-text in/out assessment Min. 10% 
duplication 
Final library of included papers 
Data extraction 
Meta-analysis & modeling 
Min. 10% 
duplication 
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Sum of losses (faeces, urine, skin, menses etc) + 
Growth & development requirements  
(foetus, pregnancy, lactation etc.) 
Dietary Requirements =     
                      Bioavailability factor 
 
 
 
 
Figure 8 Basic equation for the calculation of dietary requirements based on the sum of losses 
and requirements for growth and development adjusted by a bioavailability factor. 
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Figure 9 Schematic representation of the relationships of interest for the derivation of dietary 
reference values using the ‘dose response approach’. Study types that may provide data to 
characterise potential I-S-H associations are suggested for each possible relationship. (Figure available in color online) 
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Figure 10 Serum/plasma micronutrient concentration (pmol/L) as a function of dietary 
micronutrient intake (mcg/day), estimated by random-effects meta-analyses of observational 
studies (n=19) and RCTs (n=37), on double loge transformed scale (upper panel) and 
backtransformed scale (lower panel). In the upper panel, the line for observational studies is less 
steep, probably because of measurement errors in intake data and a smaller dose range as in 
RCTs. The overall pooled regression line (solid) of the logetransformed vitamin B12 intake and 
logetransformed serum/plasma vitamin B12 status, has a slope of 0.15 (95%CI: 0.13-0.17; upper 
panel I2=98%). This means that for every doubling in vitamin B12 intake, the difference in 
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vitamin B12 serum or plasma concentration increases by a factor is 2β i.e. 11% (=20.15 = 1.11). 
See Dullemeijer et al (2012) 
 
Figure 11 Conceptual model to derive nutrient reference values using a bivariate model for the 
intake-status relationship. Downward extrapolation results in AR- and PRI-like estimates. 
Upward extrapolation can predict the average intake of a population to serve the needs of 97.5% 
of its members. It should be noted that the method applies to populations rather than individuals. (Figure available in color online) 
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Figure 12 Scaling of reference values based on measures of body size, as selected by EURRECA 
 
 
Metabolic turnover based on the body surface area (BSA) was calculated as BSA = 
√(Weight(kg)*Height(cm)/3600), according to Mosteller {Mosteller, 1987 #115}. Therefore, 
extrapolation can be based on: 
 
Metabolic body mass and growth needs. This method for extrapolation is applied by the IOM 
(Institute of Medicine). Maintenance needs are expressed relative to metabolic body weight, 
with an extra term for growth , based on protein needs and applied for all nutrients (WHO, 
1985). This is, for example, 0.3 (i.e. 30 %) for children aged between 7 months and 3 years and 
0.15 (i.e. 15 %) for 14-18 years males and 0.0 for 14-18 year old females (Prentice, Branca et 
al. 2004).  
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Figure 13 The health space model visualises personal micronutrient recommendations. In the 
health space each person’s individual response to micronutrient interventions is visualised for 
specific biological processes (e.g. inflammation). For each biological process a multivariate 
statistical model is built, which is scaled between 0 (the average of all healthy subjects) and 1 
(the average of the unhealthy subjects). All subjects are visualised in the resulting space. 
Intervention-induced changes of the position of subjects in this space, may support involvement 
of micronutrients in health-related biological processes relevant to long term health and disease 
outcomes. A ‘real life’ example on data is published (Bouwman et al., 2012a). (Figure available in color online) 
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Figure 14 Risk curve combined with a usual intake distribution where the mean intake is less 
than the Average Requirement (AR). The mean of the usual intake distribution is 50 units and 
the majority of the intake values are less than 90 units. At 90 units, the risk of inadequacy is 
about 75 percent. Therefore, in this population, the probability of inadequacy is high. 
 
 
Figure 15 (adapted from Institute of Medicine: Dietary Reference intakes: Applications in 
Dietary Assessment; (EAR: Estimated Average Requirement) corresponds to AR). Joint 
distribution of intakes and requirements from a hypothetical population of 3,000 individuals with 
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the mean intake of 1600 units and the AR of 1200 units. The triangle labeled A is bounded by the 
intake = AR line and the 45° line where intake = requirement. Points above the 45° line (shaded 
area), represent those individuals whose intakes are above the AR, but below their own 
individual requirement. Individuals in triangle B have intakes below the AR, yet above their own 
requirement. The number of people in triangle A is approximately equal to the number in triangle 
B. 
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Figure 16 Countries with data for 7 vitamins and minerals (6 for females) classified according to 
the number of nutrients with inadequate intakes above 20% of the population. (DE= Germany ; 
DK= Denmark ; ES= Spain ; FI= Finland ; IR= Ireland ; SE= Sweden ; UK= United Kingdom). 
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Figure 17 Mean calcium intake in milligrams per day (standard deviation) by country, for males 
(o) and females (■). Countries are grouped according to region: Central and Eastern Europe, 
Mediterranean countries, Western Europe and Scandinavian countries. Red line corresponds to 
AR for adult males and females according to Nordic nutrient recommendations  
 
o males 
■    females 
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Figure 18 Median urinary iodine concentration in micrograms per litre per day by country, in 
children and adolescents in Europe (10). 
*The optimal range for median urinary iodine concentration: 100-199 µg/L 
** Source of data: WHO Vitamin and Mineral Nutrition Information System, except for studies 
from Republic of Srpska and Serbia 
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Figure 19 Mean intake of vitamin C (with their 95% confidence intervals where available) in 
lowest and highest SES group in Europe in males (M), females (F) and in both genders (MF), 
and in comparison to Average Requirement (AR). Abbreviations for countries: ES- Spain, FI- 
Finland, IE- Ireland, NL- The Netherlands, SCT- Scotland, UK- The United Kingdom, BE- 
Belgium, TR-Turkey. Abbreviations for SES indicators: educ- education, occ- occupation, inc- 
income (Novakovic et al) 
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Figure 20 EURRECA’s steps for decision making  
 
 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
3:2
6 0
5 A
ug
us
t 2
01
3 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 153 
 
Figure 21 Public Health Nutrition Policy Framework  
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